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Zytotoxische T-Lymphozyten (CTLs) spielen eine wichtige Rolle im Immunsystem 
unseres Körpers. Ihre hauptsächliche Effektorfunktion besteht darin, viral infizierte 
und tumorartige Zielzellen zu erkennen und abzutöten. Sie enthalten zytotoxische 
Substanzen wie Granzyme und Perforin in speziellen sekretorischen Vesikeln, die 
als zytotoxische Granula (CGs) bezeichnet werden und durch Exozytose an der 
als Immunsynapse (IS) bezeichneten Kontaktstelle von CTL und Zielzelle 
freigesetzt werden. Wir untersuchten, wie sich die pH-Regulierung in CGs auf die 
Funktion der primären Maus-CD8+-T-Zellen auswirkt. Wir identifizierten die a3-
Untereinheit der vakuolären ATPase als einen wichtigen Kandidaten, der für die 
Ansäuerung von CGs verantwortlich ist. Unter Verwendung eines neu generierten 
CG-spezifischen pH-Indikators bestimmten wir den pH-Wert von CGs mit 6,11 ± 
0,2. Der Knockdown der a3-Untereinheit erhöhte den pH-Wert in CGs auf 6,8 und 
führte zu einer signifikant verringerten Abtötung von p815-Zielzellen. Außerdem 
untersuchten wir die CG-Sekretion mit Hilfe der TIRF-Mikroskopie. Die Reduktion 
der a3-Untereinheit in Maus-CTLs ergab eine 75%ige Verringerung der CG-
Sekretion, die durch einen fehlerhaften Transport der CGs zur IS verursacht 
wurde. Wir haben durch elektronenmikroskopische Untersuchungen gezeigt, dass 
der a3-Knockdown in CTLs die Biogenese von CGs unverändert lässt. Aus 
unseren hochauflösenden mikroskopischen TIRF- und STED-Daten schließen wir, 
dass die a3-Untereinheit der vATPase nicht nur für die Ansäuerung von CGs 
verantwortlich ist, sondern auch zum effizienten Transport der CGs zur IS beiträgt. 
Darüber hinaus haben wir unsere Studie erweitert, um die vesikulären 
Komponenten von CGs zu identifizieren, die an der Fusion beteiligt sind. Die 
familiäre hämophagozytäre Lymphohistiozytose (FHL) ist eine genetisch bedingte 
Erkrankung, die durch Mutationen vieler Gene verursacht wird, die in 
Plasmamembran-Fusionsmaschinen funktionieren. In dieser Studie identifizierten 
wir VAMP7 als einen wesentlichen Bestandteil der vesikulären 
Fusionsmaschinerie von primären humanen CD8+T-Zellen. Eine SIM-
Mikroskopieanalyse verschiedener VAMP-Isoformen zeigte, dass nur VAMP7 
zusammen mit Granulamarkern (Granzym B und Perforin) lokalisiert ist und 
gleichzeitig mit ihnen an der IS fusioniert. Ferner verringerte die 
Herunterregulierung der VAMP7-Proteinexpression die Abtötungseffizienz von T-
Zellen bei Inkubation mit RAJI-Zielzellen signifikant. Interessanterweise 
interferierte VAMP7 nicht mit der frühen Signalgebung von T-Zellrezeptoren. 
Biochemische Assays zeigten, dass VAMP7 seine Funktion in einem SNARE-
Komplex mit Syntaxin11 und SNAP-23 an der Plasmamembran ausübt. Die 
Überexpression der VAMP7-Longin-Domäne in CTLs hemmt die Fusion von CGs 
spezifisch, ohne die Fusion von Recycling-Endosomen zu beeinträchtigen. Unsere 
Daten identifizieren die essentiellen Komponenten der Fusionsmaschinerie in T-
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Zellen. Diese Kenntnisse könnten einen Ausgangspunkt für die Entwicklung 
potenzieller Medikamente in der Immuntherapie darstellen, die auf die für VAMP7 





1.1 Cytotoxic T Lymphocytes 
Cytotoxic T Lymphocytes (CTLs) are decisive for immune surveillance against 
tumour cells and cells infected with viruses. The combined responses from both 
innate and adaptive immune systems provide the capacity to the host to fight against 
pathogens. CTLs and natural killer (NK) cells are the key players of innate or 
adaptive immunity (Peters et al., 1991). Upon activation, peripheral blood 
mononuclear lymphocytes (PBMCs) get differentiate into mature CTLs, which 
contain cytotoxic granules (CGs) with the pore-forming protein Perforin and the 
serine protease granzyme B (GzmB). Once the CTL recognizes its cognate target, 
a highly organized system of intracellular communication starts by triggering the 
TCR/CD3 complex. CTLs rapidly reorganize their cytoskeleton within minutes to 
translocate the Microtubule-organizing center (MTOC) towards the target cell 
followed by directed polarization of granules that are exocytosed for destroying 
target cells (Berke and Rosen, 1988) (Huse, 2012). Perforin monomers bind to the 
target cell membrane and assemble into multimeric complexes building pores on 
the target cell membrane that allow GzmB to enter the target cells activating 
apoptosis pathways through proteolytic substrate processing (Sutton et al., 2000) 
(Griffiths and Isaaz, 1993). 
 
Figure 1: Assembly at the CTL synapse. 
(A) Recognition of target cells by CTLs leads to the generation of the lytic immune synapse 
distinguished by the initiation of central supramolecular activation cluster (cSMAC) surrounded 
by the peripheral supramolecular activation cluster (pSMAC) and distal supramolecular 
activation cluster (dSMAC) followed by Microtubule-organizing center (MTOC) and CGs 
polarization towards the synaptic cleft. (Kabanova et al., 2018) 
 
1.2 T cell development and differentiation 
Producing the proper number and variety of cell types is critical for the physiological 
function of multicellular organisms. Most cell differentiation decisions are controlled 
by signals from widely expressed receptors that interact with germ-line ligands 
which are co-evolved (Freeman, 2000).  
Genesis of immature CD4+CD8+ thymocytes starts in the bone marrow by 
committed lymphoid progenitors which arise and migrate via the blood to the primary 
lymphoid organ thymus (Germain, 2002b). In the thymus, these cells lose the ability 
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for B-cell (Pui et al., 1999) and NK-cell (Barten et al., 2001) development. The cells 
which develop in the thymus (aka thymocytes) undergo a sequence of maturation 
steps that can be distinguished based on different markers expressed on their cell 
surface or plasma membrane. The thymus is composed of two regions, an outer 
cortex and an inner medulla. Developing thymocytes are devoid of co-receptor CD4 
and CD8 expression on their membrane during the earliest stages. These cells are 
termed double-negative (DN) committed T-cell precursors. These DN thymocytes 
undergo four sequential stages of differentiation by expressing CD44 and CD25 
(Godfrey et al., 2012). In the process of differentiation, the cells which proceed in 
the direction of the αβ TCR pathway express the pre-TCR composed of the non-
rearranging pre-Tα and rearranged TCR-β chains. Productive pre-TCR expression 
leads to increased cell multiplication along the DN4 to DP (double-positive) 
transition and ends with the pre-TCRα chain replaced with a newly rearranged TCR 
α-chain. This results in the complete formation of the αβ TCR (Germain, 2002b). 
Further, these DP (αβ-TCRCD4+CD8+) thymocytes interact with cortical epithelial 
cells which express a high density of MHC class I and II molecules associated with 
self-peptides. Too weak or too strong signaling can lead to either delayed or acute 
apoptosis. Effective maturation of T cells occurs only from the appropriate level of 
TCR signaling. CD8+ T cells originate from thymocytes that express TCRs which 
recognize self-peptide-MHC-class-I complexes, whereas CD4+ cells develop from 
TCRs that recognizes self-peptide-MHC-class-II ligands (Hazeldine and Lord, 
2015). These cells will be transported from the medulla to peripheral lymphoid sites 





Figure 2: T cell developmental scheme in the thymus. 
Dedicated lymphoid progenitors that emerge in the bone marrow relocate to the thymus where 
these cells do not express TCR, CD4, and CD8 (DN thymocytes). These cells can undergo four 
stages of differentiation (DN1, CD44+CD25-; DN2, CD44+CD25+; CD3, CD44-CD25+; and 
DN4, CD44-CD25-) (Godfrey et al., 2012). Cells that lack expression of CD44, but with CD25 
(DN3) on their surface go through a β-selection process. The β chain further pairs with the pre -
Tα and produce a pre-TCR forming a complex with CD3 molecules. This complex formation 
promotes the survival, proliferation, and arrest in further β chain loci rearrangement and 
differentiation steps later by expression of CD4 and CD8 on their surface (DP: double-positive 
cells). These DP cells undergo TCR-α-chain loci rearrangement and give rise to αβ-TCR. In the 
cortex, these cells undergo positive or negative selection (Klein et al., 2014). After selection 
process, down-regulation of co-receptor generates either naive CD4 or CD8 positive cells that 
leave the thymus and circulate in the periphery. (Germain, 2002a) 
 
1.3 Composition of cytotoxic granules 
CTLs consist of two types of killer cells called CD8+ and Natural Killer (NK) cells, 
which fight against invading virus-infected or cancerous cells. Two major pathways 
of killing target cells were described. One of the mechanisms of CTL killing is to 
invoke a strong stimulus to activate caspase by the protease granzyme B. T cell 
recognition and binding to target cell leads to exocytosis of cytotoxic granules. In 
addition to many pro-apoptotic proteins, these organelles are very complex and 
consist of other proteins found in lysosomes (Podack and Kupfer, 1991).  
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Proteins responsible for target cell destruction are present in the dense core of CGs. 
These include mainly Perforin (pore-forming protein or cytolysin), calreticulin, 
granzymes (serine proteases: Gzm A, B, C, D, E, F, G, H, J, and M) associated with 
proteoglycans rich in chondroitin sulfate, granulysin and cathepsins. Except for 
calreticulin, other proteins are expressed only in activated CTL and NK cells 
(Burkhardt et al., 1990). 
Contents of the dense core Function 
Perforin Pore formation on the target cell membrane 
Granzymes Serine proteases: pre-directed cleavage at 
specific amino acids 
Granulysin Microbial agent 
Calreticulin Binding to calcium and Perforin proteins 
Chondroitin sulfate proteoglycans Complexes to granzymes 
Cathepsin D and L Proteases 
Dipeptidylpeptidase I Activation of granzymes from pre-pro to 
active forms 
Mannose 6-phosphate receptor Granule acidification, protein trafficking 
(granzymes) 
Arylsulfatase Hydrolyse sulfates in the body 
β-Hexosamidase Ganglioside metabolism 
β-Glucuronidase Hydrolysis of β-D-glucuronic acid residues 
LAMP1 (lysosomal associated membrane 
protein 1) 
Ligand for selectins, mediates cell-cell 
adhesion 
LAMP2 (lysosomal associated membrane 
protein 2) 
Maintaining integrity, pH and catabolism 
Modified from (Smyth et al., 2001). 
 
1.4 Immunological Synapse 
The organization of membrane proteins which occurs at the interface between the 
killer T cells and the Antigen Presenting Cells (APCs) during the contacts or effector 
phase is called the Immunological Synapse (IS) (Grakoui et al., 1999). This energy-
dependent synapse formation leads to polarization of the T cell which involves 
cytoskeletal rearrangement (movement of the microtubule organizing center 
(MTOC) from the cells’ rear end to the synapse). The molecular interactions which 
regulate the immune response occur in a 15 nm gap between T cells and target 
cells or APCs (Garcia et al., 2010). Proteins such as dynein and kinesin-1 directly 
regulate the directed movement of CGs towards the IS. Immunofluorescence 
microscopy and reconstitution methods based on fluid supported lipid bilayer 
approaches helped tremendously to understand IS formation in live T cells (Monks 
et al., 1998). The mature IS is best studied between T helper cells (Th cells) and 
their conjugated APCs and consists of three clusters with central TCR-MHC (T Cell 
Receptor-Major Histocompatibility Complex) interaction cluster surrounded by a 
LFA-1-TCAM-1 adhesion molecule ring and a distal ring that consists of 
transmembrane tyrosine phosphatase CD45 termed cSMAC (central 
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supramolecular activation clusters), pSMAC (peripheral supramolecular activation 
clusters) and dSMAC (distal supramolecular activation clusters) respectively 
(Johnson et al., 2000). 
 
 
Figure 3: Formation of Immunological Synapse (IS). 
(A) A side view showing a selection of important ligand pairs and signaling molecules involved 
in T-cell recognition. The stimulatory peptide-MHC molecules (red), activating or co-stimulatory 
molecules (blue), inhibitory molecules (yellow) and grey depict the molecules that are not 
involved in the signaling pathway. The inwardly directed arrow indicates converging signals that 
divert to activation of T-cell. (B) A face-on view of the IS indicating the characteristic ‘bulls-eye’ 
zone pattern that involves cSMAC (yellow), pSMAC (green) and dSMAC (grey) regions and also 
including molecules/ligand pairs during the IS formation (Huppa and Davis, 2003).  
 
Finally, In the last phase of synapse maturation, vesicle-associated membrane 
protein 8 (VAMP8) mediates recycling endosomal fusion at the plasma membrane 
to deliver important components of fusion machinery such as factors involved in 
priming, proteins that mediate docking and soluble N-ethyl-maleimide-sensitive 
attachment protein receptor (SNAREs) (components of fusion machinery), 
responsible for CG exocytosis (de Saint Basile et al., 2010; Marshall et al., 2015b). 
 
1.5 Vesicular Fusion 
The delivery of the molecules to their precise intracellular destinations without 
compromising the structural integrity of cellular compartments is achieved by 
transport vesicles budding from one donor organelle that further target, dock, and 
fuse with another acceptor organelle (Chen and Scheller, 2001). In the nervous 
system, fusion with the plasma membrane to release vesicular content into the 
synaptic cleft is a highly coordinated calcium-dependent process (Lledo et al., 
1998). Before fusion, a vesicle is transported to its target membrane and docked or 
tethered there. It further undergoes many priming events to prepare its release 
(Klenchin and Martin, 2000) (Pfeffer, 1999). Ca2+ regulates many vesicle trafficking 
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and directional fusion events (Heidelberger et al., 1994). The cellular fusion 
machinery overcomes the repulsive ionic forces and dissipates the hydration 
between two lipid bilayers with the help of SNARE proteins (Toei et al., 2010). 
The SNARE superfamily of proteins has been implicated as primary players of 
membrane fusion in most of the intracellular membrane trafficking events. Syntaxin1 
(Bennett et al., 1992) and VAMP1 (Baumert et al., 1989) were the first membrane 
fusion proteins discovered. SNAREs have been classified as R-SNARES (arginine-
containing) or Q-SNARES (glutamine-containing) based on the presence of highly 
conserved amino acid residues (Toei et al., 2010) (Fasshauer et al., 1998). SNAREs 
vary widely in size and structure but contain SNARE motifs consisting of conserved 
60-70 amino acid (aa) heptad repeat sequences called coiled-coil domains in their 
membrane-proximal regions. More than 100 SNARE proteins have been 
categorized into syntaxin, VAMP or SNAP-25 families where many of them have 
specified cellular localization indicating their particular functional involvement in 
specific intracellular trafficking. 
                   
Figure 4: Mammalian SNAREs and their subcellular localization. 
Specific compartmental localization of mammalian SNAREs shown (red, syntaxin family; blue, 
VAMP family; green, SNAP-25 family; black, others) (Chen and Scheller, 2001).  
 
1.6 pH regulation in CGs 
Using DMAP (3-(2,4-dinitroanilino)-3’-amino-N-methyldipropyl-amine) as a pH 
probe, cytotoxic granules from OE4 (CD8+ T cell clone) cells have been found to be 
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acidic (pH 5.5 ± 0.2) and the pH increases to 6.8 ± 0.2 upon concanamycin A (CMA) 
treatment. Immunoelectron microscopy observations of these CMA treated cells 
revealed significant changes in the morphology of the CGs and reduced CG number 
(Kataoka et al., 1996). CMA induced a pH shift in CTLs with decreased levels of 
Perforin due to dissociation of Perforin from proteoglycans in a calcium-dependent 
manner. Thus, proteoglycans play an important role in sustaining the integrity of 
Perforin within the CGs for efficient target cell killing. Perforin in its free form is 
degraded by the serine proteases associated with it, to ensure the directional killing 
of the target cells while avoiding killing of bystander cells (Kataoka et al., 1997). 
Taken together, acidic pH plays a pivotal role in preserving lytic machinery of CGs 
and function of CTLs. 
  
1.7 V-ATPase 
Vacuolar-type H+-ATPase (V-ATPase) is a multi-subunit membrane protein 
complex, highly conserved across different species with exceptional functions in 
many eukaryotes (Toei et al., 2010). V-ATPases acidify a wide range of intracellular 
organelles such as endosomes, lysosomes, phagosomes, autophagosomes, 
elements of Golgi apparatus (Forgac, 2007b). V-ATPases are also localized at the 
plasma membrane of osteoclasts to acidity the extracellular space between the cells 




Figure 5: V-ATPase schematic. 
Schematic representations of E.coli-F-ATPase (left) and mammalian-V-ATPase (right) with 
membrane specific F1 and V1 domains, catalytic hexamers (α3β3 and A3B3), stalks and 
membrane sectors (F0 and V0) are depicted. Red arrow denotes the direction of the chemical 
reaction, rotation of subunits and transport of protons in physiological contexts. Various isoforms 
of V-ATPase are displayed with their specific localization and some with ubiquitous expression 




1.8 V-ATPase structure 
V-ATPase is composed of 14 subunits that are organized into two domains called 
V1 and V0. Subunits (A-H) in the V1 domain are involved in ATP hydrolysis whereas 
the V0 domain utilizing a rotary mechanism to pump protons across cell membranes 
carries out proton transport Qin et al., 2012). The central stack of the V-ATPase is 
made up of D, F and d subunits that are rotated from the energy generated by ATP 
hydrolysis within the V1 domain. Every protonated glutamic acid residue that is 
situated on each subunit of the proteolipid ring comes in contact with an ‘a’-subunit 
hemichannel at the luminal side. Due to the stabilization of the deprotonated 
glutamic acid by a crucial arginine residue from subunit ‘a’, the proton is released 
into the lumen (Forgac, 2007b) (Cotter et al., 2015). It has been shown that subunit 
‘H’ regulates the V-ATPase activity by reversibly dissociating the V1 and V0 domains 
(Diab et al., 2009). The specific V-ATPase inhibitors identified to date such as 
bafilomycin and CMA bind to the proteolipid ring of the V0 domain. These drugs 
inhibit by intercalating into the proteolipid ring of V0 domain and prevent the helical 
swiveling required for the transport of protons (Toei et al., 2011) (Cotter et al., 2015).  
Mammalian V0 domain of V-ATPase is more complicated than the V0 of F-ATPase 
in structure and subunits. The ‘a’ subunit in mammalian V-ATPase consists of four 
isoforms (a1, a2, a3 and a4). The presence of a particular ‘a’ isoform determines 
the specific localization of V-ATPase or determines the specific organelle 
localization in different cell types (Figure 6) (Toyomura et al., 2000). a1-isoform is 
mainly targeted to synaptic vesicles and from there it could be transported to the 
presynaptic plasma membrane (Morel et al., 2003). In humans, a2-isoform is 
involved in Golgi function and also in the development of congenital disorders of 
glycosylation (Kornak et al., 2008) (Marshansky and Futai, 2008). The a3-isoform 
is mainly expressed in osteoclasts and its mutation leads to 50 % of osteopetrosis 
cases in humans (a lethal disease with defective bone resorption). a3-isoform is 
also important for insulin secretion from β-cells of pancreatic islets (Sun-Wada et 
al., 2006). The a4-isoform is predominantly expressed in the kidney, where it is 
targeted to the apical plasma membrane of collecting duct and epididymal clear 




Figure 6: Schematic showing of distinctive targeting of the ‘a’ subunit isoforms and 
vesicular trafficking of eukaryotic V-ATPases. 
The above scheme displays the compartments of endo (yellow/red) and exocytic (grey) 
pathways. Red and blue arrows indicate vesicular trafficking steps for endo- and exocytosis 
respectively. Four a-subunit isoforms being targeting to specific subcellular locations were 
shown. (Marshansky and Futai, 2008) 
 
1.9 V-ATPase in membrane fusion 
Vesicular trafficking is an important process required for inter-organelle 
communication in eukaryotes. This involves tightly regulated steps such as budding 
of vesicles from one donor compartment to fusion with an acceptor compartment or 
membrane (Marshansky and Futai, 2008). In addition to the role of V-ATPase in 
acidification, its direct involvement in budding and fusion of vesicle has been 
reported. For yeast vacuole biogenesis, the direct involvement of c-subunit of V0 
sector has been reported (Baars et al., 2007). In contrast to vesicle fusion, vacuole 
fission and fragmentation in vivo also depend on the proton pumping action of V-
ATPase. In Drosophila melanogaster, the a1-subunit isoform is responsible for 
fusion of synaptic vesicles, and also interacts with calcium-binding messenger 
protein calmodulin at fly synapses. Similarly, in Caenorhabditis elegans, the 
secretion of Hedgehog related proteins from exosomes to the apical membrane is 
mediated by a1-subunit of V-ATPase (Marshansky and Futai, 2008) (Liegeois et al., 
2006). Specifically, observations from (Klemmer et al., 2009) and (Di Giovanni et 
al., 2010b) provided evidence of specific V0 subunit (c-subunit) interaction with 
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membrane trafficking machinery such as synaptophysin, synaptobrevin2, and Rab7 
in various cell types. These data corroborate the function of V-ATPase in membrane 
fusion. 
               
Figure 7: Model showing the V0 interaction with Syb2 and Ca2+/calmodulin. 
(A) The four transmembrane domains of c-subunit are depicted (numbered 1-4). Syb2 binding 
site has been mapped in the loop region of c-subunit between 3 and 4 transmembrane domains 
(broken circle). This domain also has been shown to interact with Ca2+/calmodulin. (B) 
Bafilomycin A, syntaxin-1, and Ca2+/calmodulin binding sites were shown (Morel and Poea-
Guyon, 2015). 
 
1.10 Infantile malignant osteopetrosis 
In humans, mutations in the a3-subunit isoform (TCIRG1: 116-kD protein) are 
responsible for most of the cases with a severe form of infantile malignant 
osteopetrosis (rare autosomal recessive disease; MIM 259700) generally within the 
first 10 years of life. In affected individuals, the osteoclasts are present in normal or 
increased numbers with the only defect in the functional capacity of mature 
osteoclasts (Gerritsen et al., 1994). Some other cases showed defects in both 
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osteoclast differentiation and function (Marks et al., 1985) (Kong et al., 1999; Lazner 
et al., 1999; Marks et al., 1985). More than 120 mutations have been described in 
TCIRG1 gene including missense mutations, stop mutations, deletions or insertions, 
splicing defects, and large genomic deletions leading to autosomal recessive (ARO) 
cohort (detailed in the table from (Palagano et al., 2018)). Currently, the only 
established and reliable cure for ARO is hematopoietic stem cell transplantation 
(HSCT) allowing the restoration of bone resorption from donor-derived cells. The 
genetic heterogeneity of osteopetrosis disease sets out a challenge for molecular 
diagnosis. 
 
Figure 8: Representation of molecular players in pathogenesis of osteopetrosis.   
The well-known disease causing genes are showed in black (bold) and newly identified are 
showed in orange (bold) (Palagano et al., 2018). 
 
Recent studies on osteoclasts from a3-knockout mice showed that a3-subunit 
directly recruit specific co-factors including small GTPases Rab7a and Rab27a (in 
GDP-bound forms) and play an important role in the trafficking of lysosomes to the 
cell periphery for bone resorption, which is abrogated in a3-knockout mice. But a3-
knockout (KO) did not affect the early endosomal and Golgi localization in 
osteoclasts (Matsumoto et al., 2018). 
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1.11 Longin-SNARE proteins 
There are three subfamilies of longin SNAREs identified. They are Ykt6, VAMP7, 
and Sec22b. In addition to the coiled-coil domain that induces fusion, VAMP 
proteins from the longin-SNARE family consist of a long N-terminal domain, which 
aids in membrane fusion by regulating the assembly of trans-SNARE complex 
(Filippini et al., 2001). The N-terminal regions of longin SNAREs consist of α-β-α 
sandwich architecture in contrast to an autonomously folded three-helix bundle in 
Habc domain of syntaxins. Genetic analysis showed that alternative splicing of the 
human VAMP7 gene can give rise to an isoform lacking a SNARE coiled-coil 
domain. This eventually leads to different tissue expression pattern and subcellular 
localization with unknown function (Vacca et al., 2011) (Daste et al., 2015).  
Longin domain of VAMP7 has an auto-inhibitory role on neurite outgrowth upon 
overexpression whereas its deletion has the opposite effect, indicating an 
additional function as ‘on/off’ switch for - fusogenic activity in addition to their 
regulatory function in localization of SNAREs to their site of action. Similarly, 
deletion of the longin domain showed increased spontaneous Ca2+-independent 
fusion of synaptic vesicles that contain VAMP7 (Hua et al., 2011). Further, the auto-
inhibitory role of VAMP7 was confirmed by NMR data that disclosed the adaptation 
of a closed conformation of VAMP7 in solution with the help of 126-160 aa residues 
from the SNARE coiled-coil domain. The aa leucine (43rd) and tyrosine (45th) on 
the longin domain were shown to be critical for longin domain interaction with the 
coiled-coil domain. In particular, mutation of tyrosine to glutamate modifies the 
protein structure from the closed to an open conformation (similar to the effect of 
tyrosine phosphorylation). This results in increased SNARE complex formation and 
also VAMP7-mediated vesicle exocytosis in-vivo. Surprisingly, VAMP7, in its 
closed conformation, still interacts with Varp (GDP-GTP exchange factor (GEF) for 
Rab21) and stabilizes its interaction with t-SNARE partner SNAP25 (to a lower 
extent compared to VAMP7 without a longin domain) (Vivona et al., 2010a) (Burgo 
et al., 2013). Further, VAMP7 longin domain can directly interact with coat 
components of clathrin-coated vesicles (δ-adaptin subunit AP3D1 of adaptor 
protein 3 complexes; AP-3) targeting VAMP7 to synaptic vesicles as well as to late-
endosome and lysosomal compartments. Another crucial interacting partner of 
VAMP7 longin domain is HIV Rev-binding protein (Hrb). This interaction is 
responsible for the efficient retrieval of VAMP7 from the plasma membrane during 
endocytosis (Chaineau et al., 2008a). These findings suggest two important 
regulatory functions of the VAMP7 longin domain controlling SNARE complex 
formation and ensuring precise intracellular localization of VAMP7 through specific 




Figure 9: Main functions of longin SNAREs (overview) 
Various functions of longin SNAREs Tkt6 (red), Sec22b (green) and VAMP7 (blue) (Daste et 
al., 2015b). 
 
1.12 Vesicle associated membrane protein (VAMP7) 
VAMP7 is derived from the Synaptobrevin-like 1 (SYBL-1) gene that is located in 
the pseudoautosomal region at the termini of the long arm of the X chromosome 
(Chaineau et al., 2009). It is ubiquitously expressed and conserved in eukaryotes 
(plants and flies to rat, mice, primates and humans) (DEsposito et al., 1996). Due 
to epigenetic mechanisms, SYBL-1 is transcriptionally inactive on the Y 
chromosome (Matarazzo et al., 2002). The SYBL-1 gene encodes a 2576 bp cDNA 
and generates a 220 aa containing protein with 25 kDa molecular weight. VAMP7 
(also known as tetanus neurotoxin-insensitive VAMP; TI-VAMP) differs in only 12 
aa from VAMP2 (Galli et al., 1998). It is an R-SNARE that is involved in important 
cellular functions including mitosis, cell migration, phagocytosis, membrane repair, 
and growth. It accomplishes these functions mainly by mediating the fusion of 
Golgi, late endosome and lysosomal compartment derived vesicles with the 
plasma membrane (Rossi et al., 2004) (Chaineau et al., 2009a). VAMP7 mediates 
fusion of transport vesicles and delivers lipids, adhesion proteins and growth 
factors for neurite outgrowth during neuronal development in PC12 cells (Martinez-
Arca et al., 2000). In granulocytes (eosinophils and neutrophils) VAMP7 has been 
identified as a major SNARE involved in secretion of stored mediators from 
crystalloid and azurophilic granules by using antibody-mediated inhibition studies 
(Logan et al., 2006a). In YT-Indy (an NK-cell line) (Marcet-Palacios et al., 2008a) 
and NK-cells (Krzewski et al., 2011b), siRNA mediated silencing of VAMP7 
resulted in defective exocytic release of granzyme B and reduced target cell killing. 
In allergic and non-allergic inflammatory disorders, mediator release from mast 
cells (MC) is a critical step. Human MC express VAMP3, VAMP7, VAMP8 and low 
levels of VAMP2. Using specific neutralizing antibodies against the cytoplasmic 
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NH2-terminal region and antibodies against SNAP-23, SNARE interactions 
between SNAP-23, STX-4, VAMP7 or VAMP8 were blocked resulting in a striking 
reduction in histamine release mediated by high-affinity IgE receptor (Sander et 
al., 2008b). In platelets, immunoprecipitation experiments revealed that VAMP7 
associates with VPS9-domain ankyrin repeat protein (VARP) and Arp2/3, linking 
exocytosis of granules and actin reorganization (Koseoglu et al., 2015). To 
investigate the role of VAMP7 in vivo, (Sato et al., 2011) generated VAMP7 
knockout (KO) mice and showed that the KO mice were almost identical compared 
to control, displaying similar epithelial cell polarity and lysosomal exocytosis. 
However, neurite outgrowth in cultured hippocampal neurons was reduced in KO 
mice.  
Interestingly, in mouse primary CD4+ T cells VAMP7 is involved in the recruitment 
of a vesicular pool of Lat (linker for activation of T cells) to TCR-activation sites and 
in phosphorylation of the vesicular pool of Lat (Larghi et al., 2013b). However, this 
Lat recruitment was independent of tetanus neurotoxin-sensitive SNARE proteins 
such as VAMP1, VAMP2 and VAMP3. This defective recruitment of Lat to the TCR 
activation sites leads to defective T cell signaling during antigenic stimulation of T 
cells. 
In B-lymphocytes, VAMP7 is associated with LAMP1 containing lysosomes, which 
are recruited and docked at the center of the B-cell IS. A decrease in VAMP7 
expression on lysosomes does not change lysosomal transport to the synaptic 
interface but affects their local exocytosis which leads to the inability of B-cells to 
extract, process and presents immobilized antigens (Obino et al., 2017).  
 
1.13 Genetic defects affecting cytotoxicity of lymphocytes 
Many factors affect the complex coordinated series of steps in CTL activation such 
as biogenesis, polarization and exocytosis of CGs and lastly many players involved 
in efficient killing of target cells (Lieberman, 2003) (Stinchcombe et al., 2004) 
(Stinchcombe et al., 2006). Mutations in SH2DIA gene (encoding the SLAM-
associated protein (SAP)) that is expressed in T and NK cells leads to fulminant 
infectious mononucleosis that is associated with X-linked proliferative syndrome 
(XLP) (Latour and Veillette, 2004). Mutations in the gene encoding β subunit of the 
adaptor protein AP3 (involved in lysosomal protein sorting from early endosomes) 
has been linked to Hermansky Pudlak Syndrome type II (HPS II) (Clark et al., 
2003). CTLs isolated from HPS II patients show defective polarization of CGs to 
the IS. Another disorder known as Griscelli Syndrome type II (GS II) is 
characterized by mutations in Rab27a gene. Rab27a is a small GTP-binding 
protein that interacts with effectors to enable tethering of CGs to the IS (Menasche 
et al., 2000). Familial hemophagocytic lymphohistiocytosis (FHLH3) is a disorder 
caused by mutations in UNC13D, a gene encoding Munc13-4. FHLH3 is 
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characterized by early-onset HLH and defective priming of CGs leading to reduced 
cytotoxicity of T cells (Feldmann et al., 2003). In human CD8+ T cells, syntaxin11 
(Stx11) acts as a t-SNARE for the fusion of CGs at the IS (Halimani et al., 2014). 
Patients suffering from mutations in Stx11 gene (cause of FHL4) show many 
clinical symptoms such as hepatosplenomegaly, hypercytokinemia, neurological 
alterations, hyperactivation of polyclonal CD8+ T cells and macrophages (Bryceson 
et al., 2007). Perforin deficiency leads to a FHL2 disorder characterized by the 
defective entry of protease granzyme B into the target cells leading to inefficient 
target cell killing (Voskoboinik et al., 2005). Perforin deficiency accounts for 30-40 
% of the total FHL incidence. Mutations in MUNC18-2 and lysosomal trafficking 
regulator protein (LYST) genes cause FHL5 (Cote et al., 2009) and Chediak-
Higashi syndrome (characterized by abnormal granule size) respectively (Nagle et 
al., 1996). In summary, the altered function of SNAREs and SNARE associated 
proteins lead to severe defects in lymphocyte function both in humans and mice. 
 
1.14 Aim of the work 
The killing capacity of CTLs depends upon the efficient fusion and release of 
cytotoxic materials at the IS. The proton gradient generated by V-ATPase is used 
by an antiporter to fill synaptic vesicles with neurotransmitters. Empty vesicles are 
fused due to the loss of acidification in synaptic vesicles. Loss of a1-subunit in 
Drosophila melanogaster leads to complete loss of neurotransmission. 
Chromophore assisted photoinactivation of the a1-subunit in chromaffin cells and 
in primary rat neuronal culture leads to disruption of secretion (Poea-Guyon et al., 
2013). Works from many groups indicate that the V-ATPase membrane sector is a 
missing link between acidification and exocytosis.  
In this study, we aim to understand the role of V-ATPase a3-subunit in CTL 
function. We hypothesize that a3-subunit plays an important role in acidification of 
CGs and subsequently aids in fusion of CGs by interacting with the v-SNARE 
(Syb2). Alternatively, the a3-subunit might play a role in the trafficking of CGs to 
the IS by recruiting Rab proteins which in turn interacts with kinesin motor proteins 
that transport the vesicles along the microtubules. Further, we aim to investigate 
the role of a3-subunit in the biogenesis and maturation of CGs. We extended our 
studies to investigate the molecular machinery underlying CTL-mediated target cell 
killing in primary human CD8+ T cells. 
 
The immunological synapse shares a similar structural pattern with neuronal 
synapses by forming an interface between an activated T cell and an antigen-
presenting cell or target cell. In the neuronal synapse, signaling molecules called 
neurotransmitters are released by the axon terminal of a presynaptic neuron and 
bind to and react with the receptors on the dendrites of the postsynaptic neuron. 
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Whereas, at the immune synapse cytotoxic granules containing cytotoxic 
substance fuse at the IS resulting in death of the target cells. In both the synapses 
(neuronal and immune), the fusion of transport vesicles is mediated by SNAREs. 
Coordinated interplay between many proteins are necessary from the recognition 
of target cells by CTLs to the formation of a functional IS, which end with target cell 
apoptosis or death involves many complex processes that include intracellular 
interactions, directional trafficking of CGs towards the IS and final fusion. Mutations 
in many of these genes lead to severe immune reactions such as FHL. The 
identification of cognate SNARE partners and modulators required for CG 
trafficking and fusion at the IS is important to understand the molecular 
mechanisms underlying CTL-mediated target cell killing in humans.  
In this study, we aim to understand the role of VAMP7 in cytotoxic granule 
trafficking to the IS and their final fusion. Importance of VAMP7 in the exocytosis 
of CGs was shown in NK cell lines. However, its precise mechanistic role in the 
fusion of CGs in primary human CD8+ T cells is enigmatic. CTLs display defective 
polarization of CGs towards the IS and reduced target cell killing upon VAMP7 
silencing. Here, we aim to discover functional role of VAMP7 in primary human 







Chemical substance Company (cat/order number) 
Agar-Agar Roth (5210.3) 
Ammonium persulphate Bio-Rad (1610700) 
BSA Sigma-Aldrich (A4503) 
Bromophenol blue Roth (A512.1) 
β-Mercaptoethanol  Roth (4227.3) 
Chloroform Sigma-Aldrich (288306) 
Carbonyl cyanide 3-chlorophenylhydrazone 
(CCCP) 
Sigma-Aldrich (C2759) 




Dithiothreitol Sigma-Aldrich (10197777001) 
D-Biotin IBA Lifesciences (2-1016-002) 
Dodecylsulphate Na-salt in pellets (SDS) Roth (2326.2) 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich (D8418) 
dNTP-Mix Fermentas (R0192) 
D-PBS (1X) Thermo Fisher Scientific  
(14190-094) 
Ethanol (100%) Roth (5054.1) 
Ethidium bromide Roth (2218.2) 
Ethylenediamine tetraacetic acid disodium salt 
(EDTA) 
Sigma-Aldrich (E6635) 
Glucose Merck (1.08342.1000) 
Glycerol Sigma-Aldrich (G5516) 
Glutamax Thermo Fisher Scientific (35050061) 
Heat inactivated Bovine Serum (FBS) Gibco (10500) 
HEPES Thermo Fisher Scientific (15630080) 
Hybond N+ nylon membrane GE Healthcare (RPN119B) 
Deoxyribonucleic acid from herring sperm  Merck (D3159) 
HPLC water Thermo Fisher Scientific (11307090) 
Hydrochloric acid Merck (9057.1000) 
Isopropanol Roth (AE73.1) 
Ionomycin calcium salt Merck (407952) 
Kanamycin  Sigma-Aldrich (K-1377) 
KCl Merck (1049360500) 
L-Glutamine 200 mM (100X) Gibco (25030-024) 
Methanol (100%) Roth (HN41.1) 
NaCl Merck (1064040500) 
N, N, N’, N’- Tetramethyl ethylenediamine (TEMED) Merck (1107320100) 
NuPAGE LDS sample buffer 4X Thermo Fisher Scientific (NP0007) 
NuPAGE MES SDS Running Buffer 20x Thermo Fisher Scientific (NP0002) 







2.1.2 Commercial Kits 
L-Glutamine 200 mM (100X) Gibco (25030-024) 
Methanol (100%) Roth (HN41.1) 
NaCl Merck (1064040500) 
N, N, N’, N’- Tetramethyl ethylenediamine 
(TEMED) 
Merck (1107320100) 
NuPAGE LDS sample buffer 4X Thermo Fisher Scientific (NP0007) 
NuPAGE MES SDS Running Buffer 20x Thermo Fisher Scientific (NP0002) 
NuPAGE Transfer Buffer 20x Thermo Fisher Scientific (NP00061) 
Penicillin/streptomycin Gibco (15140122) 
Paraformaldehyde Merck (1040051000) 
Phusion High-Fidelity DNA polymerase Thermo Fisher Scientific (F530L) 
Poly-L-ornithine Sigma-Aldrich (P4957) 
pfu-Polymerase Fermentas (EP0501) 
Ponceau S solution 0,1% Sigma-Aldrich (P7170) 
PAGE ruler Prestained Protein Ladder Thermo Fisher Scientific (26616) 
Restore Western Blot Stripping Reagent Thermo Fisher Scientific (21059) 
Roti Nanoquant 5x Roth (K880) 
Rotiphorese Gel 40 (37, 5:1) Roth (T802.1) 
Spectra Multicolor Broad Range Ladder Thermo Fisher Scientific (26634) 
Super Signal West Dura Extended Thermo Fisher Scientific (34075) 
Super Signal West Pico Chemiluminiscent 
Substrate 
Thermo Fisher Scientific (34076) 
Strep-Tactin XT Superflow 50% suspension IBA Lifesciences (2-4010-002) 
20 % Sarcosyl Sigma-Aldrich (L7414) 
Tryptone/Peptone Roth (8952.3) 
Trypan blue solution Sigma-Aldrich (93595) 
Triton X-100 Sigma-Aldrich (T8787) 
Tris-hydrochloride Roth (9090.3) 
Tween 20 Roth (2727.1) 
Water  Sigma-Aldrich (W4502) 
Kits Company (cat/order number) 
EndoFree Plasmid Maxi Kit Qiagen (12362) 
QIAquick PCR Purification Kit Qiagen (28106) 
Plasmid Midi Kit Qiagen (10023) 
Plasmid Mini Kit Qiagen (27106) 
QIAquick Gel Extraction Kit Qiagen (28706) 
Nucleofection kit for mouse T cells Lonza (VVPA-1006) 
P3 Primary Cell 4D- Nuclofector X Kit L Lonza (V4XP-3024) 
DynabeadsTM FlowCompTM Mouse CD8 Kit Thermo Fisher Scientific (11462D) 
DynabeadsTM UntouchedTM Mouse CD8 Cells Kit Thermo Fisher Scientific (11417D) 
DynabeadsTM UntouchedTM Human CD8 Cells Kit Thermo Fisher Scientific (11348D) 
DynabeadsTM FlowCompTM Human CD8 Kit Thermo Fisher Scientific (11362D) 






Antibodies Species Dilution Company (cat/order 
number) 
Primary antibodies  
anti-alphatubulin rabbit ICC 1:500 Abcam (4074) 
Alexa Fluor488 anti-CD107a 
(LAMP-1, clone 1D4B) 
mouse FACS 1:400 Biolegend (121607) 
Human anti-CD3ε (B-B11) mouse 30μg/ml Diaclone (854.010.000) 
Mouse anti-CD3ε (clone145-2C11) hamster 30μg/ml BD Pharmingen (553057) 
anti-Tcirg1 (a3 subunit) rabbit ICC 1:200 Thomas Jentsch (Leibniz-
Institut fur Molekulare 
Pharmakologie, Berlin, 
germny) 
anti-FLAG TAG rabbit WB 1:5000 Cell Signaling (2368) 
anti-granzyme B  mouse WB 1:3000 Cell Signaling (4275S) 
Alexa Fluor 647 anti-human 
Perforin (DG9)  
rabbit ICC 1:200 
 
BioLegend (308109) 
anti-Perforin 1 mouse WB 1:1000 Santa Cruz (136994) 
Alexa Fluor 647 anti-granzyme B 
(GB11) 
rabbit ICC 1:200 
 
BioLegend (515405) 
anti-GAPDH (clone 14C10) rabbit WB 1:5000 Sigma Aldrich, (2118L) 




(Erk1/2) (Thr202/Tyr204)  
rabbit WB 1:1000 Cell Signaling (9101) 
anti-SNAP-23  rabbit WB 1:2000 Synaptic Systems (111203) 
anti-Syntaxin 11  rabbit WB 1:2000 Synaptic Systems (110113) 
anti-Tcirg1 (a3 subunit) rabbit WB 1:2000 ProSci (6973) 
anti-VAMP7  rabbit WB 1:2000 Novus Biologicals (NBP2-
32232) 
anti-VAMP2 (D6O1A) rabbit WB 1:2000 Cell Signaling (13508) 
Secondary antibodies    
Alexa 488 conjugated anti-rabbit 
IgG 
goat 1:2000 Thermo Fisher Scientific 
(A27034) 
Alexa 568 conjugated anti-rabbit 
IgG 
goat 1:2000 Thermo Fisher Scientific (A-
11011) 
Alexa 488 conjugated anti-mouse 
IgG 
goat 1:2000 Thermo Fisher Scientific 
(A28175) 
HRP-conjugated anti-mouse IgG goat 1:1000 Thermo Fisher Scientific 
(31430) 
HRP-conjugated anti-rabbit IgG goat 1:10,000 Thermo Fisher Scientific 
(31460) 
HRP conjugated anti-Strep-tagII 
 





DynabeadsTM Human T-Activator CD3/CD28  Thermo Fisher Scientific (111.32D) 
NuPAGETM 10% Bis-Tris Protein Gels, 1.0 mm, 
10-well Thermo Fisher Scientific (NP0301BOX) 
NuPAGETM 10% Bis-Tris Protein Gels, 1.5 mm, 
10-well Thermo Fisher Scientific (NP0315BOX) 
NuPAGETM 12% Bis-Tris Protein Gels, 1.0 mm, 
10-well Thermo Fisher Scientific (NP0341BOX) 
NuPAGETM 4-12% Bis-Tris Protein Gels, 1.0 mm, 




2.1.4 Media for cell culture and solutions 
Media (Company (cat/order 
number)) 
Supplements 
IMDM (GIBCO) (21980-032) 10% FCS, 50μM 2-Mercaptoethanol, 0.5% 
Pen/Strep 
RPMI (GIBCO) (21875-034) 10% FCS, 50μM 2-Mercaptoethanol, 0.5% 
Pen/Strep, 10mM HEPES 
AIM V (for mouse primary CD8+ T cells) 
(GIBCO) (12055-091) 
10% FCS, 50μM 2-Mercaptoethanol 
AIM V (for human primary CD8+ T cells) 
(GIBCO) (12055-091) 
10% FCS 
Erythrocyte lysis buffer (pH: 7.3) H2O, 100 ml, NH4Cl, 0.829 g, (155 mM), 
KHCO3, 0.1 g, (10 mM), EDTA from 50 mM 
stock-260 μl, pH 7.4 (0.1 mM) (Bzeih, H 2016) 
Isolation Buffer 
 
PBS, 500 ml, BSA 0.5 g, (0.1%), EDTA from 
0.5 M stock solution, 2 ml, (2 mM) (Bzeih, H 
2016) 
Extracellular buffer for TIRF measurements:  
0 mM calcium buffer 
155 mM NaCl, 4.5 mM KCl, 5 mM HEPES, 3 
mM MgCl2, (pH: 7.4 and Osmolarity: 300-310 
mOsm) (Bzeih, H 2016) 
10 mM calcium buffer 140 mM NaCl, 4.5 mM KCl, 5 mM HEPES, 2 mM 
MgCl2, 10 mM CaCl2 (Bzeih, H 2016) 
Solutions for immunocytochemistry  
Fixation 4% PFA in 1X D-PBS 
Permeabilization 0.1% triton-X100 in D-PBS 
Blocking 0.1% triton-X100 in D-PBS+ 2% BSA 
Solutions for western blot  
Lysis buffer  
 
50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 250 
uM PMSF, 1% Triton-X100, 1 mM 
Deoxyclolate, 1 mM EDTA, 1 mM DTT and 1 
protease inhibitor tablet (Roche), and H2O 
Lysis buffer for Twin-Strep-tag pulldowns 300 mM NaCl, 0.5 % NP-40 or Triton X-100 50 
mM, 50 mM Tris-HCl (pH-7.5), 1 protease 
inhibitor tablet (Roche) and H2O  
TBS (10X) 87.7 g NaCl, 24 g Tris-Cl (pH 7.5) and H2O up 
to 1 L 
1X TBST (0.1%) (1L) 10x TBS-100 ml, Tween 20-1 ml and H20 up to 
1 L 
 
2.1.5 Mounting medium 
Mounting medium was prepared by dissolving 6 g Glycerol, 2.4 g Mowiol 4-88 in 6 ml 
H2O and stirred for 2 h at room temperature and 12 ml of 0.2 M Tris-HCl buffer (pH 8.5) 
was added and stirred at 53 °C overnight. The solution was centrifuged at 1700g for 20 




2.2.1 Primary CD8+ lymphocytes isolation 
Mouse CD8+ T cells 
C57BL/6 wild type (WT), homozygous Synaptobrevin2-mRFP knock-in (Sybki), 
granzyme B-TFP Knock-in, mice were used for experiments. Spleens from 8-30 
weeks old mice were taken out and gently crushed through a 70μm cell-strainer 
(Corning Life Sciences). RPMI medium was used to collect and mix the 
splenocytes which were spun down without a break (in a centrifuge). Splenocytes 
were incubated with erythrocyte lysis buffer for 30 s to remove erythrocytes. Cells 
were immediately washed with isolation buffer and CD8+ T cells were isolated 
using Dynabeads FlowComp Mouse CD8 Kit (Thermo Fisher Scientific) according 
to the user manual. Briefly: the CD8+ T cells were positively isolated from 
splenocytes by incubating 5x107 cells with 25 μl of anti-CD8 antibody for 10 min on 
ice followed by washing with isolation buffer. Later, 75 μl of CD8 antibody-coated 
Dynabeads were added to the cells and mixed gently on the rocker at 4° C. Finally, 
cells were detached from Dynabeads using releasing buffer followed by an 
isolation buffer. CD8+ T cells were then collected and resuspended in AIM V culture 
medium supplemented with 10% FCS with 50 μM 2-Mercaptoethanol. 
Human CD8+ T cells 
Human peripheral blood mononuclear cells (PBMCs) were isolated from healthy 
donors by density gradient centrifugation (Lymphoprep; Axis-Shield). Isolated 
PBMCs were stimulated with SEA (5 μg/ml) at a density of 108 cells/ml at 37°C for 
1 h. The stimulated PBMCs were resuspended at a density of 1.5 × 106 cells/ml in 
complete medium (AIMV medium; Thermo Fisher Scientific) supplemented with 
10% FCS (Thermo Fisher Scientific) and 100 U/ml of recombinant human IL-2 
(Biosource). After 5 days, SEA-specific CTLs were positively isolated by using a 
Dynal CD8+ isolation kit (Thermo Fisher Scientific) and cultured further in complete 
medium. For some experiments, CTLs from day 1-2 after positive isolation were 
used. For some experiments, CD8+ T cells were isolated from PBMCs by negative 
magnetic selection (CD8+ negative isolation kit; Thermo Fisher Scientific) and 
further activated with CD3/CD28 beads (Chitirala et al., 2019). 
 
2.2.2 Activation of naive cells 
Mouse CD8+ T cells 
The isolated naive CD8+ T cells were cultured for 3 days at a density of 1x106 
cells/mL in AIM V medium at 37°C with 5% CO2 in 24-well plate with additional anti-
CD3/CD28 activator beads (1:0.8 ratio) and 100 U/ml recombinant IL-2 to generate 
effector CTLs (Bzeih, H 2016). Cells were split after every 2 or 3 days in culture by 
adding fresh AIM V medium supplemented with 100 U/mL IL-2 (Thermo Fisher 
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Scientific). All experiments were performed using the cells from day 2 to day 15 in 
culture. 
Human CD8+ T cells 
The isolated naive CD8+ T cells were cultured for 2 days at a density of 1.5x106 
cells/mL in AIM V complete medium at 37°C with 5% CO2 in 6-well plate with 
additional anti-CD3/CD28 activator beads (1:0.8 ratio) to generate effector CTLs. 
All experiments were performed using the cells after 2 days of activation. 
 
2.2.3 Electroporation 
Mouse CD8+ T cells 
Mouse cells from day 2 to 15 were used according to the experiment and 
electroporated with a Lonza Mouse T cell Nucleofector Kit (Lonza). Briefly, cells 
(2-5 x 106 cells/transfection) were washed with warm isolation buffer once and 
resuspended in 100 µl of nucleofection solution supplied in the kit. Depending on 
the construct, 1-5 μg of plasmid DNA was used per transfection. Cells were mixed 
with DNA and then electroporated using an electroporation device (Lonza). After 
electroporation, cells were immediately transferred to mouse T cell nucleofector 
medium (Lonza). Depending on the experiment, cells were used after 8 to 16 h of 
transfection. 
Human CD8+ T cells 
For human, CD8+ T cells were used after 2 days of activation for transfection using 
P3 Primary Cell 4D-Nucleofector X Kit (Lonza). Briefly, (2-5 x 106 cells/transfection 
and 1-5 μg of plasmid DNA) were used and electroporated using a 4D 
electroporation device (Lonza). After electroporation cells were immediately 
transferred to AIM V complete medium. Depending on the experiment, cells were 
used after 8 to 16 h of transfection. 
 
2.2.4 Target cell culture 
RAJI (target cells for human CD8+ T cells) and P815 (target cells for mouse CD8+ 
T cells) cells were cultured in RPMI medium (Thermo Fisher Scientific) containing 
10 % FCS and P/S antibiotics. 
 
2.2.5 Plasmids 
Mouse CD8+ T cells 
The pH and chloride sensor ClopHensorN was purchased from Addgene (50758). 
ClopHensorN was cloned in pMAX vector by digesting the pCDNA3-ClopHensorN 
plasmid with HindIII and blunted the DNA with DNA polymerase 1, large (Klenow) 
fragment followed by digestion with NotI. The same was performed for pMAX 
vector and both vector and insert were ligated. ClopHensorN (Q69M) construct 
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was generated by mutating glutamine at the 69th position in E2GFP to methionine 
by using forward primers 5’-ATG TAT ACT AGC TAG CTG GAG CCA CCC GCA 
GTT C-3’, 5’- ACG GCG TGA TGT GCT TCA-3’ and reverse primers 5’- TGA AGC 
ACA TCA CGC CGT-3’, 5’- ATG TAT ACG CGG ATC CGC GCT TGT ACA GCT 
CGT CCA T-3’. Citrine was amplified from D1ER (gift from Adolfo lab) using 
forward primer 5’- ATG TAT ACC GGA ATC CAT GGT GAG CAA GGG CGA G-3’ 
and reverse primer 5’-ATG TAT ACG CGG ATC CTT ACT TGT ACA GCT CGT 
CCA T-3’ and cloned in pMAX vector. GzmB-Citrine was cloned by replacing 
mCherry at the C-terminus of GzmB with forward primer 5’- ATG TAT ACG CGG 
ATC CAC CGG TCG CCA CCA TGG TGA GCA AGG GCG AG-3’ and reverse 
primer 5’- ATG TAT AAA AGC GGC CGC TTA CTT GTA CAG CTC GTC-3’. 
Citrine-TdTomato was cloned by replacing E2GFP from pMAX-ClopHensorN 
plasmid with TdTomato by using forward primer 5’- ATG TAT ACC GGA ATT CGG 
TGG GAG CGG CGG AAG CGG CGG TAA GCT TAT GGT GAG C-3’and reverse 
primer 5’-ATG TAT ACG CGG ATC CCT TGT ACA GCT CGT CCT T-3’. Citrine-
TagRFP-T was cloned by amplifying TagRFP-T with forward primer 5’-ATG TAT 
ACG CAC CGG TAT GGT GTC TAA GGG CGA A-3’ and reverse primer 5’- ATG 
TAT ACC GCT CGA GTT ACT TGT ACA GCT CGT C-3’. mt-ClopHensorN (Q69M) 
was cloned by amplifying mt signal sequence with forward primer 5’-ATG TAT ACG 
GGG TAC CGC CAC C ATG TCC GTC CTG ACG CCG-3’ and reverse primer 5’- 
ATG TAT ACC GGA ATT CCC CCA ACG AAT GGA TCT T-3’.  
Human CD8+ T cells 
Human VAMP3, VAMP4, VAMP7, and VAMP8 constructs that were used in this 
study were purchased from Addgene (42310, 42313, 42316 and 42311). VAMP7 
coding sequence was amplified from pEGFP-VAMP7 plasmid (42316; Addgene) 
with forward primer 5′-ATA TAC GGG GTA CCG CCG CCA CCA TGG CGA TTC 
TTT TTG CT-3′ and reverse primer 5′ ATA TAC CGG AAT TCT TTC TTC ACA 
CAG CTT GG-3′ and inserted in frame with C-terminal mCherry with forward primer 
5’- ATA TAC CCA AGC TTA TGG TGA GCA AGG GCG AG-3’ and reverse primer 
5’- ATA TAC GCG GAT CCT TAC TTG TAC AGC TCG TCC AT-3’ or inserted in 
frame with pHuji with forward primer 5’-ATG TAT ACC CAA GCT TAT GGT GAG 
CAA GGG CGA G-3’ and reverse primer 5’-ATG TAT ACG CGG ATC CTT ACT 
TGT ACA GCT CGT C-3’ in pMAX containing GGSGGSGGS linker. Similarly, 
human VAMP8-mCherry, GzmB-mCherry, GzmB-mTFP, and msVAMP2-mRFP 
constructs which have been used for colocalization analysis (Chitirala et al., 2019) 
and TIRF experiments were previously described (Marshall et al., 2015; Matti et 




2.2.6 Semi-quantitative PCR 
The total RNA from primary cells was extracted with TRIzol (Thermo Fisher 
Scientific) and reverse transcribed (SuperScript II; Thermo Fisher Scientific) using 
random hexamer primers. Semi-quantitative PCR was performed using specific 
primers as shown below. Data were normalized to GAPDH. 
Mouse CD8+ T cells 
Primer name Sequence (5’ to 3’) 
a1 Forward primer TCA GTA CCT GAG GAA GAA GC 
a1 Reverse primer CTG GTG GAC CAT GGT GTC GC 
a2 Forward primer CGA GAA GTG ACG TGT GAG GA 
a2 Reverse primer ACT GAA CTT GGA GGA GAG CA 
a3 Forward primer CGA ACC ACC TGA GCT TTC TC 
a3 Reverse primer CCC ATG GAA GAG CAG ATG AT 
a4 Forward primer GCA GTG CAT CAT TGC CGA GAT 
a4 Reverse primer GAA CAT AGG CTG GAC ACT CCA AG 
GAPDH Forward primer ACC ACA GTC CAT GCC ATC AC 
GAPDH Reverse primer TCC ACC ACC CTG TTG CTG TA 
 
Human CD8+ T cells 
Primer name Sequence (5’ to 3’) 
VAMP4 Forward primer CCT TCG AAG TTG TTT GGA TC 
VAMP4 Reverse primer GGA CCA AGA TTT GGA CCT AG 
GAPDH Forward primer ACC ACA GTC CAT GCC ATC AC 
GAPDH Reverse primer TCC ACC ACC CTG TTG CTG TA 
 
2.2.7 PCR protocol 
Component 50 μl reaction Final concentration 
H2O 35.5 μl  
5X Phusion HF Buffer 10 μl 1X 
10 mM dNTPs 1 μl 200 μM each 
Forward primer 1 μl 0.5 μM 
Reverse primer 1 μl 0.5 μM 
Template DNA 1 μl 50-100 ng 
Phusion DNA Polymerase 0.5 μl 0.02 U/μl 
 
Cycle step Temperature Time Cycles 
Initial Denaturation 98 °C 30 s 1 
Denaturation 98 °C 30 s  
35 Annealing 60 °C 30 s 
Extension 72 °C 15-30 s/kb 
Final Extension 72 °C 10 min 1 
End 4 °C ∞  
 
2.2.8 Western blot analysis 
After activation, transfection or siRNA treatment, cells were homogenized with a 
syringe or yellow tip in lysis buffer (50 mM Tris (pH 7.4), 1 mM EDTA, 1% Triton X-
100, 150 mM NaCl, 1 mM DTT, 1 mM deoxycholate, protease inhibitors, and 
PhosSTOP (Roche) on ice. Lysates were rotated on a rocker for 10 min at 4°C, 
and insoluble material was removed by centrifugation at 10-13,000 RPM. Further, 
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Quick Start Bradford 1x Dye Reagent (5000205; Bio-Rad) was used to determine 
the protein concentration. Samples were boiled with 1X loading buffer (Thermo 
Fischer Scientific) at 98°C for 10-15 min. Later, proteins were separated by SDS-
PAGE (NuPAGE; Thermo Fisher Scientific), transferred to nitrocellulose 
membranes (Amersham), and blocked by incubation with 5% skim milk powder in 
1X TBS with 0.1% Tween-20 for 1-2 h and blotted with specific antibodies. Blots 
were developed using enhanced chemiluminescence reagents (SuperSignal West 
Dura Chemoluminescent Substrate; Thermo Fisher Scientific). For densitometry 
analysis, the pixel area and mean fluorescence intensity (MFI) were determined 




siRNAs were purchased from QIAGEN. 
Mouse CD8+ T cells 
siRNA Sequence (5’ to 3’) (cat/order 
number) 
Control siRNA UUC UCC GAA CGU GUC ACG UTT 1022076 
a1 siRNA AAG GUC AUU UAC AAU UUG CUA SI00907249 
a2 siRNA CUG GGU AGA AUU UCA GAA CAA SI00907270 
a3 siRNA1 CAU GCU CAC CCU GAA CCC UAA SI05141577 
a3 siRNA2 CUG GCC AUG GUC CUC ACU UGA A SI05141570 
 
Human CD8+ T cells 
siRNA Sequence (5’ to 3’) (cat/order 
number) 
Control siRNA UUC UCC GAA CGU GUC ACG UTT 1022076 
VAMP7 siRNA1 GAU UGG AAU UAU UGA UUG ATT SI04376134 
VAMP7 siRNA2 GGG CAA UCG UGU CGC UAA UTT SI04212453 
VAMP4 siRNA1 AGA UUG CUG CAU AAU UUA ATT SI03019653 
 
2.2.10 Conjugation of T cell with target cells 
Mouse CD8+ T cells 
To conjugate mouse primary CTLs with P815 target cells, CTLs were mixed with 
target cells at a ratio of 10:1 or 20:1 and plated onto poly-L-ornithine coated or 
CD3ε coated glass coverslips and incubated at 37°C for 15 min. Later, cells were 
fixed with ice-cold 4% PFA in Dulbecco’s 1xPBS (Thermo Fisher Scientific) and 
stained with respective antibodies.  
Human CD8+ T cells 
The stimulation of Raji cells was performed in 96-well plates with a maximum of 
one million cells resuspended in 100 μl AIM V medium. Human primary CTLs were 
mixed with target cells at a 10:1 ratio and plated on poly-L-ornithine coated or CD3ε 
coated 12 mm or 25 mm glass coverslips and incubated at 37°C for indicated time 
points (5, 10 and 15 min) respectively. Cells were fixed with ice-cold 4% PFA in 
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Dulbecco’s 1XPBS (Thermo Fisher Scientific) and stained with respective 
antibodies.  
 
2.2.11 Structured Illumination Microscopy (SIM) 
The SIM setup was a Zeiss Elyra PS1 Zeiss, Oberkochen). We acquired images 
with a 63x Plan-Apochromat (NA 1.4) with laser excitation at 488, 561, and 635 nm 
for respective fluorophores and then processed to obtain higher resolution images 
without background using Zen software (Zen 2012; Carl Zeiss). For co-localization 
analysis, Pearson’s and Manders’ overlap coefficients were determined using the 
JACoP plugin of ImageJ v1.46. 
 
2.2.12 Total internal reflection fluorescence (TIRF) microscopy 
Mouse CD8+ T cells 
CTLs isolated from granzyme B-mTFP knock-in mice were electroporated with 
either ns-siRNA or siRNA1 or 2 against the a3 subunit. For some experiments, 
CTLs were electroporated with a GzmB-mCherry construct. After 12-16 h of 
transfection, 0.2-0.3 x 106 cells were resuspended in 30 μl of extracellular buffer 
solution (2 mM HEPES, 140 mM NaCl, 4.5 mM KCl, and 2 mM MgCl2) containing 
no Ca2+ and allowed to settle for 1-2 min on anti-CD3ε antibody (30 μg/ml) coated 
coverslips. Cells were then perfused with extracellular buffer containing 10 mM 
Ca2+ to trigger cytotoxic granule exocytosis. Depending on the constructs used and 
the experimental conditions, cells were imaged for 7 min at room temperature 
either 561 nm or 488 nm. Unless specified otherwise, acquisition frequency was 
10 Hz and the exposure time was 100 ms (Chitirala et al., 2019). 
Human CD8+ T cells 
The TIRFM setup from Visitron Systems GmbH (Puchheim, Germany) was custom 
built based on an IX83 (Olympus) equipped with the Olympus autofocus module, 
a UAPON100XOTIRF NA 1.49 objective (Olympus), a 488 nm 100 mW laser and 
a solid-state 100 mW laser emitting at 561 nm, the iLAS2 illumination control 
system (Roper Scientific SAS, France), the evolve-EM 515 camera (Photometrics) 
and a filter cube containing Semrock (Rochester, NY, USA) FF444/520/590/Di01 
dichroic and FF01-465/537/623 emission filter. Visiview software was used to 
control the setup (Version: 4.0.0.11, Visitron GmbH). CTLs from different donors 
were electroporated with the indicated plasmids to image fusion in TIRFM. For 
some experiments, CTLs were electroporated with GzmB-mCherry or VAMP7-
mCherry or VAMP7-pHuji or rab11-mCherry plasmids. After 12-16 h of 
transfection, 0.2-0.3 ×106 cells were harvested and resuspended in 30 μl of 
extracellular buffer (2 mM HEPES, 140 mM NaCl, 4.5 mM KCl, and 2 mM MgCl2) 
containing no Ca2+ and allowed to settle for 1-2 min on anti-CD3ε antibody (30 
μg/ml) coated coverslips. After 1 or 2 min the cells were perfused with extracellular 
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buffer containing 10 mM Ca2+ to induce cytotoxic granule exocytosis. Depending 
on the constructs and the experimental conditions, cells were imaged for 7 min at 
room temperature (RT = 22 ± 2°C) either at 561 nm or at 488 nm or alternating 
between both illuminations. Unless specified otherwise, the acquisition frequency 
was 10 Hz, and the exposure time was 100 ms. Images and time-lapse series for 
cytotoxic granule fusion were analyzed using Time Series Analyzer plugin (ImageJ 
(http://imagej.nih.gov/ij), or the FIJI package of ImageJ)) (Chitirala et al., 2019). A 
sudden rise in VAMP7-pHuji fluorescence or a sudden drop in VAMP7-mCherry, 
GzmB-mTFP, GzmB-mCherry or Rab11-mCherry fluorescence occurring within 
300 ms (three acquisition frames) was defined as fusion (Ming et al., 2015).  
 
2.2.13 Electron Microscopy 
Mouse CD8+ cells isolated from GzmB-mTFP knock-in mouse 5 days after 
activation by anti-CD3/anti-CD28 beads were treated with siRNA (details 
Praneeth). After 16 hours of transfection, 4000 CTLs in AIMV media with 30 % 
FCS were seeded onto Poly-L-ornithine (0.1 mg/ml) coated 1.4 nm sapphire discs 
in flat specimen carriers (Leica). The cells were allowed to settle for 20 min at 37° 
C with 5 % CO2. Samples were vitrified in a high-pressure freezing system (Leica 
EM PACT2/RTS) in AIMV with 30 % FCS. All samples were further processed in 
an automatic freeze-substitution apparatus (Leica AFS2) as described in (Matti et 
al., 2013a). In brief, all samples were transferred into the precooled (-130°C) 
freeze-substitution chamber of the AFS2. The temperature was increased from -
130 to -90° C for 2 h. Cryo-substitution was performed at -90°C to -70° C for 20 h 
in anhydrous acetone and -70° C to -60° C for 20 h with 0.3 % (w/v) uranyl acetate 
in anhydrous acetone. The samples were infiltrated with increasing concentrations 
(30, 60 and 100 % for 1 h each) of Lowicryl (3:1 K11M/HM20 mixture) with 0.3 % 
uranyl acetate. After 5 h of infiltration with 100 % Lowicryl, samples were UV 
polymerized at -60° C for 24 h and for an additional 15 h while the temperature 
was raised linearly to 5° C (Chang et al., 2018).  
Ultrathin sections were cut using a Leica EM UC7 and collected on pioloform-
coated copper grids after contrasting with uranyl acetate and lead citrate sections 
were analysed with a Tecnai12 Biotwin electron microscope (FEI). 
 
2.2.14 Correlative fluorescence electron microscopy 
Cells were prepared for high pressure freezing as described before, but samples 
were vitrified in a high high-pressure freezing system (Leica EM PACT2/RTS) 5 
min after addition of CellMask deep red (Invitrogen, 1:2000) in AIMV for plasma 
membrane staining. In contrast to the described freeze-substitution protocol, the 
samples for correlative microscopy were infiltrated with increasing concentrations 
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(30, 60 and 100 % for1 h each) of Lowicryl (3:1 K11M/HM20 mixture) without 0.3 
% uranyl acetate, to avoid background fluorescence during high resolution SIM. 
After freeze-substitution the samples were kept in the dark at 4° C until further 
processing. 100-120 nm ultrathin sections were cut by using an EM UC7 (Leica). 
The sections were collected on carbon-coated 200 mesh copper grids (Plano). 
Fluorescence analysis was performed within 1 d after sectioning to avoid loss of 
fluorescence signals. 
For correlative fluorescence and electron microscopy, the grids were placed in a 
drop of water between two coverslips, sealed with silicone (picodent twinsil®). High-
resolution SIM (ELYRA PS.1; Zeiss) images were acquired by using the 63x Plan-
Apochromat (NA 1.4) with excitation light of 488 nm and 642 nm wavelengths and 
processed. After imaging in the bright-field mode for grid orientation, CellMask 
deep red image (642 nm) was recorded to identify both the image plane and the 
outline of CTLs by plasma membrane staining. In a z-stack analysis, 3-8 anti-
RFP488 images (488 nm) and CellMask deep red images (642 nm) were recorded 
with a step size of 100 nm to scan the cells of interest. For data acquisition and 
image processing for higher resolution ZEN 2010 software (Carl Zeiss Microscopy 
GmbH) was used.  
After fluorescence analysis, the very same grids were stained with 2% uranyl 
acetate and lead citrate and analysed with a Philips Tecnai12 Biotwin electron 
microscope (FEI). Only CTLs with well-conserved membranes, cell organelles and 
nuclei were analysed and used for correlation. 
For correlation, the CellMask deep red image, which shows the labelled plasma 
membrane of the cells, was used to find the optimal overlay with the EM image. 
The final alignment with the anti-RFP488 image defines the position of the 
fluorescent signal within the cells of interest. Images were overlaid in Corel Draw 
(Chang et al., 2018).   
 
2.2.15 Analysis of cytotoxic granule accumulation in the TIRF 
plane  
ImageJ v1.46 software was used to determine the number of CGs that appeared 
at the TIRF plane. The background was subtracted from the raw data stacks and 
a threshold value was set for all cells to mark the CGs specifically. For every frame 
of the time-lapse movie, the value of the pixel defined as the threshold area was 
obtained from each cell. The ratio between the threshold area and the number of 
vesicles from three frames from every cell was calculated. To obtain the number 
of vesicles appearing in each frame, the area threshold was divided by the ratio 
from all the time frames. The average number of vesicles or CGs from the indicated 




2.2.16 Calcein-AM killing assay 
Raji cells were pulsed with SEA (1 μg/ml) for 30 min at 37°C and cells after washing 
with 1XPBS were loaded with calcein-AM (500 nM; Thermo Fisher Scientific) in 
serum-free AIMV media for 15 min at RT. Cells were washed with 1XPBS once 
and plated onto 96-well black plates with clear bottoms (BD Falcon). One well of 
the target cells was lysed with Triton X-100 (0.1%) to calculate maximum target 
cell lysis as control. CTLs were electroporated with ns-siRNA or siRNA1 or 2 
against VAMP7. After 16-18 h, CTLs (0.2 × 106 cells/well) were added to target 
cells in 10:1 or 20:1 ratio to measure killing at 37°C for 4 h. Readings were 
measured at 485 nm excitation wavelength and 535 nm emission wavelength by 
GENios Pro plate reader. The fluorescence for the experimental conditions was 
adjusted by the parameter γ according to the live target cell control fluorescence. 
The γ value was measured at time zero by using the formula, 
γ = F(live) (0)/F(exp) (0) 
 F(live) = fluorescence of target cells only 
F(exp) = fluorescence of target cells + CTLs 
 
The cytotoxicity was calculated from the loss of calcein fluorescence in target cells 
using the following equation,  
 
% target cell lysis = (F(live) − γ × F(exp))/(F(live) – F(lyse)) × 100%. 
 
F(lyse) = maximum target lysis  
For details see (Kummerow et al., 2014). All experiments were performed in 
duplicates from 3-4 donors.  
For mouse primary CTLs, p815 target cells were incubated with anti-CD3ε antibody 
(30 μg/ml) for 30 min and then the killing assay was carried out as described 
(Chitirala et al., 2019). 
 
2.2.17 Estimation of ERK phosphorylation 
1 x 106/ml primary human CD8+ T cells were activated for the appropriate time with 
anti-CD3ε (125 ng/ml) and anti-CD28 (250 ng/ml) antibodies in a volume of 1 ml. 
Cells were washed in cold PBS and lysed in lysis buffer (50 mM Tris (pH 7.4), 1 
mM EDTA, 1% Triton X-100, 150 mM NaCl, 1 mM DTT, 1 mM deoxycholate, 
protease inhibitors, and PhosSTOP; Roche) on ice. After sonication, proteins were 





2.2.18 Twin-Strep-tag pulldown assay 
20-50 x 106 of primary, human CD8+ T cells were electroporated with either Twin-
Strep-tag (used as control), VAMP7-Flag-Twin-Strep-tag or Twin-Strep-tag-Stx11 
constructs and incubated at 32°C for 12-16 h. Cells were lysed with ice-cold lysis 
buffer (50 mM Tris (pH 7.4), 300 mM NaCl, 0.5% Triton X-100, protease inhibitor 
mix (Roche)) and centrifuged at 10-13,000 RPM for 10-15 min at 4°C. After protein 
quantification with Bradford reagent, 500 μg of cleared lysate was incubated with 
125 μg Strep-Tactin-Sepharose beads (IBA Lifesciences) for 1.5-3 h at 4°C on a 
rotator. After incubation, beads were washed three times with lysis buffer at 2500 
RPM. Proteins bound to the beads were eluted with 1x NuPAGETM LDS sample 
buffer (Thermo Fisher Scientific) and heated at 98°C for 15 min for Western blot 
analysis. 50 μg (10%) of protein lysate was loaded as input (Chitirala et al., 2019). 
 
2.2.19 pH and chloride calibration 
A pH calibration curve was generated using the ratio of the fluorescence with 
illumination at 488 nm to that at 458 nm of the E2GFP moiety of ClopHensorN 
(Q69M). The AIM-V media was removed and replaced with T cell-extracellular 
solution and the cells were located under the microscope. The extracellular 
solution was then replaced with a pH-clamping solution. Solutions with pH values 
of 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8 and 8.5 were made as follows. The base solution 
consists of 30 mM NaCl, 100 mM KCl, 2 mM MgCl2, and 10 mM glucose, as well 
as 10 μM nigericin, 4 μM valinomycin and 5 μM CCCP. Depending on the target 
pH, lactate (20 mM, pH4), MES (20 mM, pH5 and pH6), or HEPES (20 mM, pH7–
9) were included. After allowing equilibration of the intracellular pH (>5 min), the 
images were acquired with sequential illumination at 488 nm, 458, and 561 nm with 
open pinhole. The whole-cell was considered for ratiometric calibration. Ratios of 
fluorescence vs pH values were fit using a sigmoidal curve (SigmaPlot 13). For pH 
measurements, the coverslips were placed in the observation chamber, filled with 
extracellular solution, and imaged at room temperature. Images were acquired at 
488, 458, and 561 nm. Ratios of fluorescence at 488 and 458 nm were calculated 
and the pH was interpolated from the calibration curve fit. The desired [Cl-]i and pHi 
were controlled by equilibrating extra and intracellular ion concentrations using the 
nigericin (K+/H+ exchanger) (5 μM), the protonophore carbonyl cyanide p-
chlorophenylhydrazone (CCCP) (5 μM), the valinomycin (K+ ionophore) (5 μM) and 
tributyltinchloride (Cl-/OH- exchanger) (10 μM) in the presence of high-K+ 20 mM 
HEPES buffer containing 0.6 mM MgSO4, 38 mM sodium gluconate and 100 mM 
potassium gluconate. The specified amount of gluconate anion was replaced by 




2.2.20 Generation of granzyme B-mTFP knockin mice 
Gzmb-mTFP KI mice were generated with the help of hCas9-D10A-mRNA 
(nickase) using a guide RNA 5’-GTCCAGGATTGCTCTAGGAC-3’ (PAM = AGG). 
Stop codon in the 5th exon of granzyme B was removed and replaced with mTFP 
in frame with a flexible linker sequence GGSGGSGGS. A Homology Directed 
Repair (HDR) fragment was designed to introduce mTFP in the genome. To 
confirm the correct location of the HDR fragment, sense 5’-ATC AAA GAA CAG 
GAG AAG ACC CAG-3’ (upstream HDR to mTFP) and sense 5’-ACC GCA TCG 
AGA TCC TGA ACC-3’ primers were used. For PCR, sense wt primer 5’-CAA CAG 
CTC AGT GCC TTG TAT CCA-3’ and sense KI primer 5’-ACC GCA TCG AGA 
TCC TGA ACC-3’ and Antisense wt primer 5’-TTC ACA AGG ACC AGC TCT GT-
3’ were used. This work has been done by Fritz Benseler (in collaboration with 
Niels Brose, Max-Plank-Institut für Experimentelle Medizin, Göttingen). 
Heterozygous animals were transported to the animal facility in the Physiology 
department, Universitätsklinikum des Saarlandes, Homburg and mouse line was 
maintained as homozygous GzmB-mTFP (308).  
 
2.2.21 Synaptobrevin2 knock-in mice generation 
2.2.21.1 Cloning of Targeting vectors 
pSP73-Synaptobrevin2-mRFP targeting vector (Matti et al., 2013a) was used as a 
background vector for cloning. Synaptobrevin2-mRFP was replaced with 
Synaptobrevin2-mTFP or TagRFP-T or pHluorin2. mTFP was amplified using 
NPY-mTFP vector as a template with forward primer 5’-ATG TAT ACG GGG TAC 
CAT GGT GAG CAA GGG CGA GGA G-3’ and reverse primer 5’- ATG TAT ACC 
CAA GCT TTT GCG GCC GCT TAC TTG TAC AGC TCG TCC AT-3’. TagRFP-T 
was amplified using pCR259-TagRFP-T vector as a template with forward primer 
5’- ATG TAT ACG GGG TAC CAT GGT GTC TAA GGG CGA AGA G-3’ and 
reverse primer 5’- ATG TAT ACC CAA GCT TGA AGC GGC CGC CAG TGT GAT 
G-3’. pHluorin2 was synthesized using IDT custom gene synthesis tool from protein 
sequence (Mahon, 2011) which was codon optimized for Mus musculus. 
 
2.2.21.2 Genomic DNA isolation from tail samples  
Stock For 5 ml 
100 mM Tris-HCl, pH 8.5 500 μl 
5 mM EDTA, pH 8.0 50 μl 
200 mM NaCl 200 μl 
0.2% (W/V) SDS 100 μl 
20 μg/ml Proteinase K 5 μl/tube 
 
1. Tail samples were lysed with 500 µl tail lysis buffer (with 5µl proteinase K) 
2. Tubes were incubated overnight at 55 °C in heat block or oven. 
3. After digestion samples were centrifuged at 13000 rpm for 10 min at 4 °C 
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4. Supernatant was transferred into another eppendorf (by tumbling or with blue 
1ml tip which is cut) 
5. 3 volumes of cold 100% ethanol was added to the tubes and inverted 5-6 times 
till you see the DNA precipitation 
7. The precipitated DNA was transferred to another eppendorf, which has 1 ml 70% 
ethanol in it 
8. Tubes were centrifuged at 13000 rpm for 10 min at 4 °C 
9. Pellet was dried at RT for 30 min 
10. 80-100µl of TE buffer was added and incubate at 37 °C for 3-4 h. 
11. DNA was mixed by tapping and was run at 90V, 0.7% Agarose gel, 2X TAE 
 
2.2.21.3 Genomic DNA isolation from Embryonic Stem (ES) cells 
ES cell lysis buffer 
 
Stock Working For 50 ml 
1 M Tris-HCl, pH 7.5 10 mM Tris-HCl, pH7.5 0.5 ml 
0.5 M EDTA, pH 8 10 mM EDTA 1 ml 
5 M NaCl 10 mM NaCl 0.1 ml 
20 % Sarcosyl 0.5 % Sarcosyl 1.75 ml 
20 mg/ml Proteinase K 1 mg/ml Proteinase K 2.5 ml (added later) 
Water Water  46.65 ml  
 
To isolate genomic DNA from one 96 well plate, 12 ml of lysis buffer was taken in 
a falcon tube and 600 μl of Proteinase K was added. Vortexed briefly and sarcosyl 
was added followed by short vortexing.  
1. 96 well plate was thawed at RT for 10-15 min. 
2. 100 μl of lysis buffer was added with multichannel pipette. 
3. Plate was wrapped with parafilm and closed the lid. 
4. Plate was kept in a box with wet paper towels inside and incubated 60 °C 
overnight. 
5. Plate was centrifuged at 1500 rpm/2 min at RT and 50 μl was transferred to new 
plate. 
6. 100 μl of pre-cooled (-20 °C) 100 % ethanol + NaCl (1.5 μl of 5 M NaCl per 100 
μl ethanol). 
7. Incubated at RT for 30 min (DNA precipitation was observed under the 
microscope). 
8. Plate was centrifuged at 2500 rcf at 4 °C. Supernatant was discarded by 
tumbling the plate upside down. 
9. Washed 2 times with 70 % ethanol and centrifuged at 2500 rcf at 4 °C. One plate 
was stored at 4 °C and another were dried for 30-45 min at RT. 
 
Digestion: 
Water 39 x 110 = 4290 μl 
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Buffer O 4.5 x 110 = 495 μl 
Fermentas ASP718I enzyme 1.5 x 110 = 165 μl 
Mixed well and added 45 μl to each well (no need to mix after adding). Plate was 
incubated at 37 °C / overnight in a shaker incubator (50 rpm) in a box with wet 
paper towels inside. 
  Boast up digestion: 
Water 3.5 x 110 = 385 μl 
Buffer O 0.5 x 110 = 55 μl 
Fermentas ASP718I enzyme 1x 110 = 110 μl 
Mixed well and added to each well and plate was incubated at 37 °C / 1-2 h in a 
shaker incubator (50 rpm) in a box with wet paper towels inside. 
 
0.7 % Agarose gel:  
5.6 gm of agarose was added in 800 ml of 2 x TAE buffer with EtBr and gel was 
made using a big caster. 
 
Sample preparation: 
6 μl of 6 x loading buffer was added to each well and loaded on the gel. 
 
Transfer: 
After running, the gel was washed 3 times with denaturation buffer at 35 rpm for 
45 min (15 min each). Followed by rinsing with water and washed 3 times at 35 
rpm for 45 min (15 min each) with neutralization buffer. DNA was transferred to 
Hybond N+ nylon membrane for 36 to 48 h. 
Buffers: 
Denaturation buffer: (0.5 N KOH and 1.5 
M NaCl) /1 L 
500 ml 1 M KOH, 300 ml 5 M NaCl and 200 
ml water 
Neutralization buffer: (0.5 M Tris-HCl, 
pH 7.5 and 1.5 M NaCl) /1 L 
500 ml 1 M TRIS-HCl, 300 ml 5 M NaCl and  
200 ml water 
20 X SSC buffer: 1L (pH 7) 3 M NaCl (175.3 g), 300 mM Tri-sodium-
citrate-dihydrate (88.23 g),  
Wash Buffer A: 1L 
 
20 X SSC (100 ml), 10 % SDS (50 ml) and 
850 ml water 
Wash Buffer B: 1L 
 
20 X SSC (10 ml), 10 % SDS (10 ml) and 980 
ml water 
Speed hybrid buffer: 1L 70 g SDS, 100 g PEG 6000 (calbiochem), 75 
ml 20 X SSPE, 175.3 g NaCl + 27.6 g 
NaH2PO4.H2O + 7.4 g EDTA (pH adjusted to 




For 1L Substance Working  For 500 ml 
(in ml) 
For 250 ml 
(in ml) 
For 100 ml 
(in ml) 
500 ml Na-Phosphate 
Buffer (387 ml 1M 








Labeling of the probe: 
200-500 ng of DNA (8 μl) + Water (22 μl) was heated at 95 oC for for 5 min and 
cooled for 2-3 min 
Reaction buffer 10 μl 
BSA 2 μl 
dNTPs 2 μl 




Above mixture was added to the DNA (final volume of 50 μl) and incubated at 37 
oC for 90 min. 
Elution: 
1. For column equilibration, bottom cap was removed & loosened the upper cap 
that allows removing the buffer by gravity flow. 
2. Column was filled with TE buffer and let it flow through the column 
3. DNA sample was added to the column followed by the addition of 400 μl of TE 
4. Flow through was collected in tube 1 
5. 200ul of TE was added and flow through was collected in tube 2 and repeated 
the 5th step and collected in around 6 tubes. 
6. Counts were measured using Gamma counter (Protocol: 2, P32, 60 s). 
 
Prehybridizytion:  
Blot was incubated for 2 h at 60 oC with 15-20 ml church buffer + denatured Hering 
sperm DNA (200 μl (100 μl / ml concentration)) 
6. 2 million counts / ml was used (15-20 ml church buffer + denatured Hering sperm 
DNA (200 μl (100 μl / ml concentration)). Incubate overnight at 65 oC (rotating 
rocker). 
Washing the blots: 
1. 3 times washed with wash buffer A (30’ each) 
2. 3 times washed with wash buffer B (30’ each) 
3. Exposed to screen for 4 h or overnight. 
 
Na2HPO4 + 113 ml 
1M NaH2PO4 
350 ml 20%SDS 7 % 175 87.5 35 
110 ml 10%BSA 1 % 55 27.5 11 
2 ml 0.5M EDTA 1 mM 1 0.5 0.25 
10 ml Salmon Sperm 
DNA 
(10mg/ml)(Denatur
ate at 95oC for 10 
min and cool for 3 
min 
0.1 mg/ml    
Till 1L Water - 19 9.5 3.75 
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2.2.22 Data analysis 
For data analysis and to calculate statistical significance ImageJ v1.46 (Rasband, 
W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
https://imagej.nih.gov/ij/, 1997-2018), Microsoft Excel (Microsoft) and SigmaPlot 




3. Results  
Role of the V-ATPase in maturation and fusion of 
cytotoxic granules in mouse CTLs 
3.1 Designing a ratiometric pH sensor for measuring pH in CGs 
In order to measure pH inside and outside of CGs from primary mouse CD8+ T 
cells, we tried different pH-sensitive fluorophores. We expressed Citrine (non-
ratiometric), GzmB-Citrine, ClopHensorN (ratiometric, containing E2GFP + 
TdTomato), GzmB-ClopHensorN, Citrine-Td-Tomato (ratiometric) and Citrine-
TagRFP-T (ratiometric) constructs in CTLs. After 12-16 h of transfection cells were 
used for measurements. pH calibration was done using pH buffers ranging from 
pH 4 to pH 8.5 and protonophores for H+-permeabilisation of the membranes. For 
non-ratiometric fluorophores, at the end of each pH buffer measurement (Fx), 
NH4Cl (dequenches the fluorophore) was added to the coverslip/cells to get the 
maximum fluorescence (Fmax). The ratio of Fx/Fmax was calculated for each 
measurement and plotted in sigma plot using appropriate equations (Figure 10A & 
B). For Citrine-TdTomato and Citrine-TagRFP-T (ratiometric measurements), the 
ratio of F515 / F558 was calculated for each buffer condition and plotted in sigma 
plot (Figure 10D & E). In pH measurement using ClopHensorN, the ratio of F488 / 
F458 was taken for calibration curve generation (F458 indicates the isosbestic 




Figure 10: Generation of a ratiometric pH sensor for pH measurements in cytotoxic 
granules. 
(A-E) Primary mouse CD8+ T cells were electroporated with indicated fusion constructs. After 
12-16 h of transfection, calibration curve related to pHCG to the pH sensitive excitation 
fluorescence ratio (Fx/Fmax for citrine and GzmB-Citrine, F488/F458 for ClopHensorN, 
F515/F561 for Citrine-TdTomato and Citrine-TagRFP-T). pHCG was manipulated by adjusting 
extracellular pH in the presence of an H+ permeable ionophore, data were fit using established 
equations in sigma plot and pKa values were with a fitted 95% confidence interval. Bars indicate 
± Stdev. 
 
3.2 The ratiometric pH sensor ClopHensorN (Q69M) measures 
pH inside CGs quantitatively 
From all ratiometric and non-ratiometric pH sensors tested in our hands, we 
selected ClopHensorN, a genetically encoded ratiometric pH and Cl- sensor 
(Raimondo et al., 2013), for our pH measurements because of its dynamic range 
from 2 to 6 (see Figure 10C on the Y axis) compared to other sensors. Cytotoxic T 
lymphocytes containing CGs have been reported to be acidic (pH 5.5 ± 0.2 
(Kataoka et al., 1996). The pKa value of ClopHensorN (pKa: 7.2; see Figure 10C) 
results in poor resolution in the expected pH range so we mutated the glutamine 
at 69th position in E2GFP to methionine in order to lower the pKa value of the sensor 
(Griesbeck et al., 2001) (Figure 11A). We then tested for correct targeting of the 
sensor to CGs after expression in mouse CD8+ T cells using ClopHensorN (Q69M) 
tagged to GzmB (a CG marker) at the C-terminus with flexible GGSGGSGGS 
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linker. We also stained the cells with Alexa647 conjugated anti-GzmB antibody 
(Figure 11B) and analysed Pearson’s coefficient of correlation and Manders’ 
overlap coefficients (0.53 ± 0.04 and 0.65 ± 0.04 for GzmB to ClopHensorN 
(Q69M); 0.84 ± 0.02 for ClopHensorN (Q69M) to GzmB), which were significant 
indicating the correct localization of the sensor to CGs (Figure 11C & D). From this 
sensor we were able to determine pH and Cl- concentrations quantitatively as pH 
6.11 ± 0.13 and 73.78 ± 3.87 mM respectively (Figure 11E & F).  
From these data, we conclude that ClopHensorN (Q69M) can measure the pH 
inside CGs of CTLs in-vivo. 
 
Figure 11: Measurement of the pH in cytotoxic granules using ClopHensorN and 
ClopHensorN (Q69M) 
(A) Schematic showing the design of ClopHensorN (Q69M) and GzmB-ClopHensorN (Q69M). 
A flexible (GGS)x3 linker (yellow) used between GzmB and ClopHensorN (Q69M). (B) SIM 
images of fixed primary mouse CD8+ T cells electroporated with GzmB-ClopHensorN (Q69M) 
and immunostained with Alexa647 conjugated anti-GzmB antibody. (C, D) Pearson’s and 
Manders coefficients of co-localization between GzmB-ClopHensorN (Q69M) and GzmB (n = 
16). (E) ClopHensorN (Q69M) calibration curve related to [pH]CG to the pH-sensitive excitation 
fluorescence ratio (F488/F458). [pH]CG was manipulated by adjusting extracellular pH in the 
presence of a H+-permeable ionophore. The pKa was found to be 6.61 with a fitted 95% 
confidence interval and [pH]CG was measured to be 6.11 ± 0.13 . (F) ClopHensorN calibration 
curve relating [Cl−]CG to the Cl−-sensitive excitation fluorescence ratio (F458/F561). [Cl−]CG was 
systematically varied by controlling extracellular Cl− in the presence of a Cl−-permeable 
ionophore. The estimated Kd was 4.89 mM with a fitted 95% CI between 11.7 and 66.7 mM 
and [Cl−]CG was measured to be 73.78 ± 3.87 mM (protocol as described in Raimondo et al., 




3.3 Mitochondrial signal sequence targets the ClopHensorN 
(Q69M) to mitochondria  
To ensure the specificity of the sensor, ClopHensor was targeted to mitochondria 
by adding mitochondrial signal sequence (29 amino acids of human cytochrome 
oxidase (COX) subunit 8a) at the N-terminus of ClopHensorN (Q69M). CTLs were 
electroporated with mt-ClopHensorN (Q69M) and immunolabeled with anti-mt 
antibody to verify the colocalization with the inner mitochondrial membrane 
specifically (Figure 12B) (Manders’ overlap coefficient 0.78 ± 0.02 for ClopHensorN 
to inner membrane 0.77 ± 0.02 for inner membrane to ClopHensorN). From this 
data, [pH]mt was measured to be 7.57 ± 0.87 (Figure 12D) (as described in the 
literature (Porcelli et al., 2005)). 
 
                                   
 
Figure 12: Measuring pH in mitochondria using mt-ClopHensorN (Q69M). 
(A) Schematic showing the design of ClopHensorN (Q69M) and mt-ClopHensorN (Q69M) 
constructs. A flexible (GGS)x3 linker (yellow) used between mitochondrial signal peptide and 
ClopHensorN (Q69M). (B) Representative SIM images of fixed primary mouse CD8+ T cells 
electroporated with mt-ClopHensorN (Q69M) and immunostained with anti-mt antibody. (C) 
Manders coefficients of co-localization between mt-ClopHensorN (Q69M) and anti-mt antibody 
(n = 8). (D) ClopHensorN (Q69M) calibration curve related to [pH]mt to the pH-sensitive 
excitation fluorescence ratio (F488/F458). [pH]cytosol was systematically varied by controlling 
extracellular pH in the presence of an ionophore. [pH]mt was measured to be 7.57 ± 0.87. Bars 




3.4 Knockdown of a3 isoform of vATPase increases the pH 
inside the lumen of CGs 
After measuring the [pH]CG and [pH]mt in CTLs, we aimed to identity the mechanism 
of acidification in CGs. To this end, we searched for a candidate for granular 
acidification. From the literature, in addition to a function in acidifying various 
intracellular compartments in eukaryotes, the membrane domain (V0) of the 
vATPase has been shown to contribute to the Ca2+-dependent transmitter release 
via a direct role in vesicle membrane fusion (Giovanni et al., 2010). The V0 domain 
is a 260 kDa complex composed of six different subunits (a, c, c, c, d, and e) (Xiao 
et al., 2008). Subunit ‘a’ is a 116 kDa protein that contains four isoforms, namely 
a1, a2, a3, and a4. ‘a’-subunit isoforms confer organelle specificity (see Figure 6). 
RT-PCR analysis of a-subunit isoforms revealed that a1, a2 and a3 subunits are 
expressed in mouse CTLs (Figure 13A). Further, to know which a-subunit isoform 
is located on CGs, siRNA-mediated knockdown of a1, a2 and a3 subunits was 
performed (Figure 13B-D). Primary mouse CD8+ T cells were electroporated with 
siRNAs against a1, a2 or a3 together with a pH sensor GzmB-ClopHensorN 
(Q69M). After 12-16 h of transfection, [pH]CG was measured with reference to 
calibration curve shown in (Figure 11E). a3-subunit Knockdown alone increased 
the pH inside CGs to 6.8 ± 0.08 compared to ns-siRNA treated cells (5.9 ± 0.08). 
Whereas, in the case of a1 or a2 knockdown, [pH]CG was unchanged (5.97 ± 0.05 
and 6.08 ± 0.02 for a1 and ns-siRNA; 6.06 ± 0.07 and 6.06 ± 0.02 for a2 and ns-
siRNA, respectively) (Figure 13E). 
From this data we conclude that the a3-subunit of V-ATPase is localized on CG 
membrane and might play a role in pH regulation of CGs.  
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Figure 13: Expression of vATPase a-subunit isoforms in mouse CTLs. 
(A) PCR showing the expression of a-subunit isoforms from brain and CTLs. GAPDH was used 
as loading control. (B-C) Densitometric quantification of cDNA levels from a1 and a2-subunits 
knockdown by semi-quantitative PCR. (D) Lysates from CD3/CD28 bead stimulated primary 
mouse CTLs electroporated with either control or a3-siRNA1 or 2 respectively and blotted for 
a3 (top) and GAPDH (bottom) as loading control. Quantification of a3 protein expression levels 
(in % normalized to control siRNA-treated CTLs) by densitometry. (a3-siRNA1, N = 3; ***p < 
0.001 and anti-a3 siRNA2, N = 3; ***p < 0.001 (t-test)). (E) Stimulated mouse CTLs were co-
transfected with ns-siRNA (control) or anti-a1, anti-a2 or anti-a3 siRNA1 along with GzmB-
ClopHensorN (Q69M). After 16-18 h of transfection [pH]CG was measured in reference to 
calibration curve (Figure 11E) from the ratio (F488/F458) (N = 3, n = 167 for a3-siRNA1; n = 
333 for a1-siRNA1; n = 500 for a2-siRNA respectively). Data indicate mean ± SEM.  
 
3.5 a3-subunit of vATPase is localized on cytotoxic granules 
Further, with SIM microscopy we checked the localization of a3 subunit by 
immunostaining with anti-a3 antibody (gift from Thomas J. Jentsch, FMP, Berlin) 
in mouse CTLs isolated from synaptobrevin2-mRFP knock-in mice where 
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synaptobrevin2 was fused to a red fluorescent protein, mRFP (Matti et al., 2013b). 
a3-subunit showed significant co-localization with cytotoxic granule marker GzmB 
with Pearson’s coefficients of correlation of 0.64 ± 0.08 (Figure 14B). This confirms 
the presence of a3 isoform containing V-ATPase on cytotoxic granules. 
 
        
Figure 14: Localization of a3 subunit in mouse CTLs. 
(A) Representative SIM images from stimulated SybKI CTLs immunostained with polyclonal 
anti-a3 antibody (B) Pearson’s overlap coefficients of co-localization of SybKI with a3 are given 
in the text (N = 3, n = 25). Scale bar, 5 µm. 
 
3.6 The killing capacity of CTLs is reduced upon a3 subunit 
knockdown 
It has been shown that the loading of synaptic vesicles with neurotransmitters in 
neurons requires V-ATPase dependent acidification (Amara and Kuhar, 1993).  
(Hiesinger et al., 2005), moreover they showed that the a1-subunit of the V0 
domain is required for functional synaptic vesicle exocytosis in Drosophila v100 
mutant synapses (a1-subunit isoform in Drosophila) the size of mEPSCs were 
smaller due to a lower concentration of neurotransmitter in the synaptic vesicles. 
These findings led us to examine the transport of GzmB to the CGs upon a3-
knockdown. For that purpose, we electroporated SybKI CTLs with ns-siRNA or a3-
siRNA1 and stained CGs with Alexa 647 conjugated anti-GzmB antibody after 16hr 
of transfection. We observed no significant difference between the localization of 
GzmB in cells treated with either ns-siRNA or a3-siRNA1 which gave a Pearson’s 
coefficients of correlation of (0.71 ± 0.072 and 0.66 ± 0.08; A & B). As a functional 
assay to check the killing capacity of CTLs after down-regulating the a3-subunit by 
siRNAs, we did a calcein-AM based killing assay. After a3-subunit knockdown, 
there was a reduction in target cell lysis (12.8 ± 0.67 % and 9.46 ± 1.18 for (20:1 
and 10:1 (CTL:target cell ratio)); for a3-siRNA1, 10.66 ± 3.01 % and 9.02 ± 1.41 
for (20:1 and 10:1 (CTL:target cell ratio)); for a3-siRNA2) compared to (35.78 ± 1.2 
% and 30.09 ± 1.63 for (20:1 and 10:1 (CTL:target cell ratio)); for wt, 33.57 ± 1.81 
% and 31.1 ± 0.98 for (20:1 and 10:1 (CTL:target cell ratio)); for ns-siRNA, 31.60 
± 1.16 % and 28.7 ± 0.82 for (20:1 and 10:1 (CTL:target cell ratio)); for a1-siRNA1), 
and 30.37 ± 2.51 % and 27.67 ± 1.26 for (20:1 and 10:1 (CTL:target cell ratio)); for 







Figure 15: The a3-subunit knockdown decreases the killing efficiency of CTLs 
(A) Representative SIM images of primary CD8+ T cells isolated from SybKI mice 
immunostained with an anti-a3 antibody. (B) Pearson’s coefficients of co-localization of 
endogenously labeled synaptobrevin2 and a3-subunit are given in the text (n=11). (C) Calcein-
based killing assay for CTLs electroporated with either ns-siRNA, a1-siRNA1, a2-siRNA1, a3-
siRNA1 or a3-siRNA2 18 h after transfection. Experiments were carried out in duplicates (N = 
3; ***p < 0.001 (t-test)). Data are shown as mean ± SEM. Scale bar, 5 µm.  
 
3.7 GzmB-mTFP knock-in mice as a tool for studying v-ATPase function in 
mouse CTLs  
GzmB-mTFP knock-in mouse was generated by using CRISPR-cas9 technology 
with the help of guide RNA directly in embryonic stem cells (ES) from C57BL6/N 
mouse strain. Before using this knock-in mouse as a tool for studying the v-ATPase 
function in the present study we verified the localization of GzmB-mTFP by 
immunostaining with Alexa 647 conjugated GzmB antibody. SIM analysis showed 
significant co-localization of GzmB with endogenous mTFP-tagged GzmB protein 
(Figure 16B) with Pearson’s coefficients of correlation of (0.67 ± 0.016) and 
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Manders’ overlap coefficient of (0.75 ± 0.012 for GzmB-mTFP to GzmB and 0.76 
± 0.012 for GzmB to GzmB-mTFP; Figure 16C & D). We also validated the function 
or activity of GzmB tagged to mTFP at the C-terminus by performing a live-cell 
killing assay. We incubated GzmB-mTFP expressing CD8+ T cells with p815 target 
cells stably expressing an inverse FRET construct called Casper3-GR. This 
construct has a DEVD sequence interspaced between the FRET pair Tag-GFP 
and Tag-RFP. This side can be cleaved by caspase-3, which is indicated by a 
reduction in FRET between the fluorophore-partners; hence an increase in green 
and decrease in red fluorescence results. As shown in (Figure 16F) we observed 
an increase in donor fluorescence intensity (Figure 16F, Tag-GFP channel) over 
time, demonstrating that the GzmB protein was functional and its release leads to 
apoptosis by activating caspase-3 in target cells. After demonstrating that GzmB 
is active and localized to CGs, we tested the fusion of GzmB-mTFP containing 
vesicles at the plasma membrane in an independent assay by Total Internal 
Reflection Fluorescence Microscopy (TIRFM). After seeding GzmB-mTFP 
expressing CTLs on CD3-coated coverslips the IS was formed quickly and we 
observed a rapid accumulation of CGs, indicated by individual green (GzmB-
mTFP) puncta (Figure 16E). The Individual fusion events were quantified by a 
sudden drop in the mean fluorescence intensity of GzmB-mTFP caused by the 
release and subsequent diffusion of the soluble GzmB-mTFP (compare frame 4 
and 5 upper and lower panel of (Figure 16E). 
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Figure 16: GzmB-mTFP Knockin mice. 
(A) CRISPR cas9 mediated knockin strategy for generating GzmB-mTFP knock-in mice. (B) 
Bead stimulated primary CD8+ T cells isolated from GzmB-mTFP KI mouse on day 5 were fixed 
and stained with Alexa647 conjugated anti-GzmB antibody. (C, D) Pearson’s and Manders 
coefficients of co-localization between GzmB-mTFP and endogenous GzmB are given in the 
text (n=10). (E) Selected live-cell TIRF microscopy images of GzmB-mTFP in a CTL in contact 
with an anti-CD3 coated coverslip. Fusion events are indicated with open arrows (seven frames 
shown per granule fused). (F) Live cell killing assay showing a mouse CTL in contact with p815 
target cell stably expressing Casper3-GR (FRET construct containing Tag-GFP and Tag-RFP 
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with a target cleavage site DEVD of Caspase 3 (activated via GzmB). LSM images at indicated 
time points showing a reduction in FRET signal, indicating the killing of the target cell. Bars 
show mean ± SEM. Scale bar, 5 µm. 
 
3.8 Knockdown of a3-subunit strongly reduces the fusion of 
cytotoxic granules at the IS 
Our data demonstrate that v-ATPase a3-subunit co-localizes with the CG marker 
GzmB and its knockdown increases the pH specifically inside the CGs. To 
investigate whether the a3 subunit is involved directly in the fusion of CGs with the 
plasma membrane, we performed TIRFM experiments. For that purpose, we 
electroporated primary mouse CTLs isolated from GzmB-mTFP knock-in mice with 
two different siRNAs against a3 (siRNA1 and 2) and analysed CG fusion at the 
plasma membrane on coverslips coated with anti-CD3 antibody. In contrast to 
scrambled control siRNA, either a3 siRNA reduced the expression of a3 to >10-20 
% for a3-siRNA1 and 2 of the original level, respectively. Both siRNAs significantly 
reduced the number of CGs appearing in the TIRF plane (Figure 17A) and number 
of CTLs showing CG fusion to less than 60% of the values measured upon 
transfection of control siRNA (from 47.08 ± 2.86% to 10.09 ± 1.51% for a3-siRNA1, 
n = 161; and from 47.08 ± 2.86% to 10.99 ± 0.67% for a3-siRNA2, n = 143, 
respectively compared to ns-siRNA; Figure 17B). Simultaneously, the average 
number of CG fusion events observed in CTLs expressing either a3 siRNA was 
reduced as well (from 4.24 ± 0.33 to 2.20 ± 0.24 for a3-siRNA1; and from 4.24 ± 
0.33 to 2.28 ± 0.23 for a3-siRNA2, respectively compared to ns-siRNA; Figure 
17C). The average number of CGs appearing in the TIRF plane per cell was 
significantly reduced (4.74 ± 2.88 for a3-siRNA1; and 4.61 ± 0.90 for a3 siRNA2, 
respectively; Figure 17D) compared to (16.1 ± 2.38 for wt; and 15.96 ± 2.88 for ns-
siRNA, respectively; Figure 17D). 
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Figure 17: Knockdown of a3 strongly reduces the fusion of cytotoxic granules at the IS. 
(A) Selected live-cell TIRF microscopy images of GzmB-mTFP in a CTL electroporated with 
either ns-siRNA or a3-siRNA1 or a3-siRNA2 in contact with an anti-CD3 coated coverslip. 
Fusion events are indicated with open circles (three frames shown per granule fused). (B) 
Mouse primary CD8+ T cells isolated from GzmB-mTFP KI mouse electroporated with either 
ns-siRNA or a3-siRNA1 or a3-siRNA2 and imaged 16-18 h after transfection. The mean 
percentage of cytotoxic granule fusion in cells electroporated with either ns-siRNA (N =3 & n = 
98) or (N = 3, n = 161, **p = 0.001, t-test; for a3-siRNA1 and N=3, n=143, ***p = 0.001, Holm-
Sidak test; for a3-siRNA2 (C) Mean average number of granules fused over time in the TIRF 
plane per cell (p = **0.004, t-test; for a3-siRNA1 and **p = 0.002, Holm-Sidak test; for a3-
siRNA2). (D) The mean average number of GzmB-mTFP containing vesicles in the TIRF plane 
per cell during 7 minutes of measurements from wt CTLs or cells electroporated with either ns-
siRNA or a3-siRNA1 or a3-siRNA2 (N = 3, n = 15, ***p<0.001 (Kruskal-Wallis One Way 
Analysis of Variance on Ranks). Bars indicate mean ± SEM. Scale bar, 5 µm. 
 
3.9 GzmB levels were increased whereas Perforin levels were 
decreased in a3 Knockdown 
Having (Figure 15A) concluded that there was no defective GzmB transport to the 
CGs but in spite of a strong reduction in the fusion of CGs from TIRF experiments 
(Figure 17) we expected an increased intracellular GzmB concentration in the a3 
KD cells. As expected, we found an increase in GzmB levels in a3-KD and for 
control purposes the cells were treated with CMA (V-ATPase inhibitor) for 4 h 
compared to control (GzmB levels normalized to ns-siRNA treated cells) (100 % 
for ns-siRNA; 140.3 ± 7.35 % for a3-siRNA1; 179.4 ± 16.82 % for CMA; Figure 18A 
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& B). However, we observed a reduction in the levels of Perforin in a3-KD and 
CMA treated cells compared to control (Perforin levels normalized to ns-siRNA 
treated cells) (100 % for ns-siRNA; 55.46 ± 8.88 % for a3-siRNA1; 38.02 ± 9.11 % 
for CMA; Figure 18C) by western blot analysis. These findings suggest that after 
a3-KD, GzmB might not be released possibly due to the neutral pH inside CGs. 
The neutral pH in CGs may also induce the proteolytic degradation of Perforin. 
                      
Figure 18: GzmB and Perforin levels after a3 Knockdown. 
(A) Lysates from bead stimulated wt mouse CD8+ T cells were electroporated with either ns-
siRNA or a3-siRNA1 for 16-18 h or treated with 100 nM concanamycin-A (CMA) for 4 h and 
blotted for Perforin (top), GzmB (middle) and GAPDH (bottom) as loading control. (B) & (C) 
Quantification of GzmB and Perforin protein expression (in % normalized to control siRNA-
treated CTLs) by densitometry. Bars indicate mean ± SEM. Scale bar, 5 µm. 
 
3.10 The a3 subunit of V-ATPase did not show any interaction 
with the V-SNARE Synaptobrevin2  
Next, we tested the role of the a3 subunit in the fusion of CGs by forming a SNARE 
complex with the vesicular SNARE VAMP2 being the vSNARE in mouse CTLs 
(Matti et al., 2013b). It has been shown that the a3 subunit of vATPase is involved 
in the final step of vesicle fusion by interacting with Synaptobrevin2 (v-SNARE in 
neuronal cell types and mouse CTLs) (Di Giovanni et al., 2010a). We performed 
pulldown assays by generating a fusion protein for Synaptobrevin2 (Syb2-Twin-
Strep-tag) (Figure 19A) and electroporated mouse CTLs with this construct. 
Western blots of pull-downs from mouse CTLs expressing tagged synaptobrevin2 
did not show any interaction with a3 subunit, however, we could detect SNAP-23, 
a tSNARE partner for synaptobrevin2 (Figure 19B).  
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Figure 19: Syb2-Twin-Strep-tag pulldown assays. 
(A) Schematic showing the design of Twin-Strep-tag and Synaptobrevin2 fusion constructs 
used for pulldown assay. The Twin-Strep-tag was fused at the C-terminus of Synaptobrevin2 
connected by a (GGS)x3 linker. (B) Bead-activated mouse CTLs electroporated with Twin-
Strep-tag-tagged Synaptobrevin2 were lysed and incubated with Strep-Tactin sepharose 
beads. The precipitates were analyzed with antibodies against Strep-tag, a3-subunit, c-subunit 
and SNAP-23. 
 
3.11 The a3 subunit did not show any interaction with Rab7a or 
Rab27a in Strep-tag pulldown assays 
In osteoclasts, the a3 subunit of V-ATPase plays a role in trafficking of secretory 
lysosomes to the plasma membrane by interacting with dominant-negative GDP-
bound form of Rab7A and aids in bone resorption by providing optimal conditions. 
The a3 subunit also interacts with GDP-bound Rab27A, a key player involved in 
docking and fusion of secretory lysosomes with plasma membrane in CTLs 
(Matsumoto et al., 2018) (van der Sluijs et al., 2013). We expected a similar 
scenario in CG transport and fusion with the plasma membrane in mouse CTLs 
based on previous results from TIRFM. We performed pulldown assays by 
generating fusion proteins for Rab7A and Rab27A (Twin-Strep-tag-Rab7a, Twin-
Strep-tag-Rab7a (T22N), Twin-Strep-tag-Rab7a (Q67L) Twin-Strep-tag-Rab27a, 
Twin-Strep-tag-Rab27a (T23N) and Twin-Strep-tag-Rab27a (Q68L)) (Figure 20A 
& B) and electroporated mouse CTLs with these constructs. Western blots of pull-
downs from mouse CTLs expressing tagged Rab7A or Rab27A did not show any 




Figure 20: Rab7a and Rab27a pulldown assays. 
(A, C) Twin-Strep-tag, Rab7a and Rab27a fusion constructs used for pulldown assay. The 
Twin-Strep-tag was fused at the N terminus for Rab7a, Rab7a(T22N), Rab7a(Q67L), Rab27a, 
Rab27a(T23N) and Rab27(Q68L) connected by a (GGS)x3 linker. (B) Bead-activated mouse 
CTLs electroporated with Twin-Strep-tag-tagged Rab7a constructs (D) or Twin-Strep-tag-
tagged Rab27a constructs. Cell lysates were incubated with Strep-Tactin sepharose beads and 
the precipitates were analyzed with antibodies against Strep-tag and a3-subunit. As control, 
cells were electroporated with Twin-Strep-tag construct alone. 10% of the lysates were loaded 
as input. 
 
3.12 Cytotoxic granules from a3-silenced CTLs were away from 
microtubules  
Cytotoxic granules are transported along the microtubular network towards the IS. 
Though it is not clear which Rab protein mediate this step, if there were no 
interaction with microtubules in the absence of a3 subunit, the distance between 
CGs and microtubules would also be more. To quantitatively measure this distance 
accurately, we took advantage of STED microscopy (X, Y resolution of 50nm and 
a 100nm Z resolution). CTLs isolated from GzmB-knock-in were transfected with 
a3-siRNA1 and 2 and stained with SiR-tubulin to visualize the microtubules in live 
cells. As expected, the average distance between tubules and CGs were 
significantly higher (470 ± 29.35 nm for a3-siRNA1; 260 ± 28.04 nm for a3-siRNA2) 








Figure 21: Distance between CGs and microtubules increased upon a3 knockdown. 
(A) Selected live-cell confocal and (B) STED images from GzmB-mTFP CTLs stained with SiR-
tubulin. (C) Box plot demonstrating the mean average distance between microtubules and 
cytotoxic granules (n=20, ***p = 0.001 for a3-siRNA1 and n=20; ***p = 0.001 for a3-siRNA2 
(Holm-Sidak test)) compared to control. Bars indicate mean ± SEM. Scale bar, 1 µm. 
 
3.13 Morphology of cytotoxic granules is altered upon a3 
knockdown 
Further, we wanted to know whether the reduction in target cell killing is due to 
impairment in fusion of CGs or the biogenesis itself. Therefore, we analysed the 
average number of granules per cell after transfecting the day 1 bead stimulated 
CTLs that were isolated from GzmB-mTFP knock-in mice with ns-siRNA or a3-
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siRNA1 or 2 with structured illumination microscopy (SIM) as (12.59 ± 1.08 (n=87); 
for ns-siRNA, 12.61 ± 1.14 (n=83); for a3-siRNA1 and 12.76 ± 1.25 (n=76); for a3-
siRNA2; Figure 22A). These results indicate that a3-subunit of V-ATPase has no 
role in the biogenesis of CG. 
Since there is no biogenesis defect, there are two possibilities that could explain 
the defective CTL function. First: a3 might play a role in the fusion of CGs by 
forming a SNARE complex at the IS. Second: a3 might recruit small GTPases that 
interact with kinesin motor proteins that have been known as key molecular players 
which help in the trafficking of CGs along the microtubules to the IS (similar to an 
a3-dependent lysosomal transport mechanism shown by (Matsumoto et al., 2018). 
We also performed electron microscopy experiments to visualize the ultrastructural 
or morphological changes of CGs after a3 knockdown. EM data clearly showed 
that the avarage greyscale (indication for proteoglycan matrix with serglycin) (0-
256) was lesser upon a3-knockdown (shown in open white triangles) (123 ± 4.0 for 
a3-siRNA1 and 121 ± 5.0 for a3-siRNA2) compared to control (shown in closed 
dark triangles) (184 ± 6.57 for ns-siRNA) (Figure 22C). Also, average diameter of 
the CGs was significantly increased (353.45 ± 14.62 nm for a3-siRNA1 and 350.5 
± 19.77 nm for a3-siRNA2) compared to control (220 ± 12.81 nm) (Figure 22D & 
E). Further, by performing correlative fluorescence electron microscopy we 
confirmed that these enlarged granules were indeed GzmB positive (Figure 22B).  
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Figure 22: Ultrasturucture of CGs upon a3 knockdown.   
(A) The average number of CGs per cells in CTLs isolated from GzmB-mTFP KI mice 
electroporated with either ns-siRNA (control) or anti-a3-siRNA1 or 2 and fixed after 16-18 h of 
transfection. (B) Electron micrographs of resting CTLs obtained from GzmB-mTFP knock-in 
mice treated with ns-siRNA, a3-siRNA1 and 2 (left upper, middle and lower panel). From left to 
right: TEM image and magnified region of the TEM-image marked with the white frame.  The 
magnified inserts show organelles with electron dense areas, which were used for statistical 
analysis. Scale bar, 2 µm for the three left images (11.000x magnification) and 0.5 µm for the 
right images (30.000x magnification). (C) Representative correlative fluorescence electron 
microscopy images of resting CTLs obtained from GzmB-mTFP knock-in mice treated with ns-
siRNA, a3-siRNA1 and a3-siRNA2 (left upper, middle and lower panel). From left to right: SIM 
(MIP image)/TEM overlay and magnification of TEM image marked with the white frame. The 
magnified inserts indicate GranzymeB-positive organelles with electron dense areas. Scale bar, 
2 µm for the three left images (from top to bottom: magnification 9.300x, 11.000x and 4.800x) 
and 0.5 µm for the right images (30.000x, 30.000x and 37.000x magnification, respectively). 
(D) Mean average greyscale values of CGs (p = ***0.001 for a3-siRNA1 and ***p = 0.001 for 
a3-siRNA2 (Holm-Sidak test) compared to control. (E) Mean average diameter of CGs (p = 
***0.001 for a3-siRNA1 and ***p = 0.001 for a3-siRNA2 (Dunn’s test) compared to control. Bars 




vSNARE of human CTLs 
3.14 Fusion of cytotoxic granules is insensitive to tetanus toxin 
Since in the previous part of the thesis we could demonstrate a major role of the 
a3-subunit of the V-ATPase for maturation of CGs. We now looked deeper into the 
next step, namely, fusion of mature CGs with the plasma membrane at the 
synapse. We particularly asked for the so far unknown vesicular SNARE (vSNARE) 
of the human SNARE-complex catalysing the fusion of CGs at the IS.  In order to 
investigate the v-SNARE responsible for CG fusion in human CTLs, we used 
tetanus toxin as a tool to screen different isoforms of v-SNARE family (VAMPs). 
Tetanus toxin (TeNT) is a zinc-endopeptidase from anaerobic Clostridia bacteria 
that specifically cleaves VAMP1, VAMP2 (synaptobrevin2) and VAMP3 
(cellubrevin), but not VAMP4, VAMP7 (TI-VAMP) (Chaineau et al., 2009) or 
VAMP8 (Humeau et al., 2000; Proux-Gillardeaux et al., 2005). We expressed 
primary, bead stimulated day 3 human CD8+ T cells with the protease-containing 
light chain of TeNT and tested its function by western blot to compare the 
expression levels of VAMP2 and VAMP7 (Figure 23A). As expected, TeNT 
expression (with 71.8 ± 7.2% transfection efficiency) resulted in effective cleavage 
of VAMP2 (27.6 ± 1.3% expression) compared to CTLs expressing only GFP 
(control) (68.5 ± 8.3% transfection efficiency) while the protein levels of VAMP7 
was unchanged (92.1 ± 0.9% and; Figure 23B). Further, to visualize and quantify 
fusion of individual CGs upon TeNT expression we performed total internal 
reflection fluorescence microscopy (TIRFM) (Figure 23C). Representative still 
images for individual fusion events from GFP or TeNT electroporated CTLs are 
represented with open arrows. Five frames were shown for one fusion event. The 
percentage of CTLs showing fusion events were similar between CTLs expressing 
TeNT and CTLs expressing only GFP (36.7 ± 4.71 % for TeNT and 39.8 ± 5.9% 
for GFP; Figure 23D). The average number of granules that fused at the IS was 
similar in both groups (2.2 ± 0.5 for TeNT and 2.3 ± 0.4 for GFP; Figure 23E). From 
these data we conclude that CG secretion from primary, human CD8+ T cells is 
uninfluenced by TeNT, eliminating VAMP1, VAMP2, and VAMP3 as candidates 




Figure 23: Fusion of cytotoxic granules with the plasma membrane is insensitive to 
Tetanus toxin. 
(A) Bead-activated human CD8+ T cells were electroporated with control GFP or TeNT-GFP 
constructs as described. Protein levels of VAMP2 and VAMP7 were determined by Western 
blot analysis after 12-16 h of transfection. (B) Densitometric quantification of VAMP2 and 
VAMP7 protein levels relative to GAPDH in CTLs that were electroporated with GFP or TeNT-
GFP constructs (N=3, ***p < 0.001 (Student’s t-test)). (C) Human CTLs were co-transfected 
with either GFP or TeNT-GFP constructs along with granzyme B-mCherry and imaged after 12 
h of transfection. Representative live-cell TIRFM images of CTLs that were in contact with anti-
CD3 coated coverslips. Fusion events indicated with open arrowheads. (D) Mean percentage 
of cytotoxic granules fused in cells electroporated with either GFP (n=50) or TeNT-GFP (n=40), 
p = 0.704 (Student’s t-test)). (E) Mean average number of granules fused per cell over time in 
the TIRF plane in cells electroporated with either GFP (n=20) or TeNT-GFP (n=15), p = 0.939 




3.15 VAMP7 is expressed in CTLs and up-regulated upon 
activation  
All the SNAREs from VAMP1 to 8 were expressed at the mRNA level in primary 
CD8+ T cells and some VAMPs accumulate at the IS when conjugated with target 
cells (Pattu et al., 2012). From the TeNT treatment experiment (Figure 23) we could 
eliminate VAMP1, 2 and 3 as potential v-SNAREs for CG fusion. Further, we 
activated CTLs with CD3/CD28 beads and checked the expression levels of 
VAMP2 and VAMP7 proteins with western blot analysis in CTLs from day 0 to day 
5. VAMP7 levels were up regulated following activation (N = 3, 100 to 180.08 ± 
37.03%), whereas VAMP2 levels were decreased (N = 3, 100 to 46.94 ± 12.83%; 
Figure 24A & B). Data were normalized to GAPDH and set to 100% on day 0. 
Taken together, this increase in VAMP7 protein levels upon activation of CTLs 
suggests that VAMP7 might play an important role in CD8+ T cell function. 
   
 
Figure 24: VAMP7 and VAMP2 protein levels after CTL activation over time. 
(A) VAMP2 and VAMP7 protein expression in naive and bead-activated CD8+ T cells for the 
indicated days determined by Western blot analysis. (B) Graphs represent VAMP2 and VAMP7 
levels normalized to GAPDH. (N = 3, p = 0.222 (day 1), p = 0.0505 (day 2), p = 0.0142 (day 3), 
p = 0.0178 (day 4) and p = 0.0274 (day 5); (t-test)). Bars indicate mean ± SEM. Adapted from 
(Chitirala et al., 2019). 
 
3.16 VAMP7 shows a high degree of co-localization with 
cytotoxic granules 
To examine the localization of VAMPs in primary human CD8+ T cells, we used 
super-resolution structured illumination microscopy (SIM) with 100 nm resolution 
in the x, y, and 300 nm in z planes. Because there are only a few paralog-
specificvantibodies available, we electroporated EGFP coupled fusion proteins of 
VAMP3, VAMP4, VAMP7 and mTFP coupled VAMP8 together with the CG marker 
GzmB coupled with mCherry in primary CTLs derived from human blood (Figure 
25A). From the three TeNT-insensitive VAMP isoforms tested, VAMP7 showed the 
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highest Pearson’s coefficient of correlation (0.7 ± 0.02) (Pearson, 1909) and 
Manders’ overlap coefficient (Manders et al., 1993). In contrast, VAMP4 showed 
little overlap with the CG marker, resulting in Pearson’s (0.29 ± 0.02 for VAMP4, 
0.22 ± 0.22 for VAMP2 and 0.23 ± 0.02 for VAMP3) and Manders’ values (0.4 ± 
0.02 for VAMP4 to GzmB, 0.52 ± 0.3 for GzmB to VAMP4, 0.43 ± 0.013 for VAMP2 
to GzmB, 0.38 ± 0.026 for GzmB to VAMP2 and 0.33 ± 0.016 for VAMP3 to GzmB, 
0.46 ± 0.033 for GzmB to VAMP3) comparable to the TeNT-sensitive VAMP2 and 
VAMP3 which were used as controls (Figure 25B & C). Previous studies have 
shown that VAMP8 colocalizes with recycling endosomes and also is responsible 
for the fusion of Rab11-positive recycling endosomes with the plasma membrane 
prior to CG fusion (Marshall et al., 2015) and had an intermediate Pearson’s 
coefficient of correlation (0.51 ± 0.033; Figure 25A & B). Since VAMP7 exhibited 
the highest coefficient of correlation with CGs, we can conclude that VAMP7 is the 
most likely candidate to mediate CG exocytosis in human CD8+ T cells. To validate 
this conclusion, we immunostained GzmB with an Alexa 647-conjugated anti-
GzmB-specific antibody. This antibody also exhibited a high degree of co-
localization with expressed EGFP-VAMP7 or VAMP7-pHuji constructs with a 
Pearson’s coefficient of correlation (0.61 ± 0.02 from EGFP-VAMP7 to GzmB and 
of 0.62 ± 0.023 from VAMP7-pHuji to GzmB) and a Manders’ overlap coefficient 
(0.70 ± 0.014 from EGFP-VAMP7 to GzmB and 0.75 ± 0.009 from VAMP7-pHuji 




Figure 25: VAMP7 co-localizes with cytotoxic granules significantly. 
(A) Bead-activated primry human CD8+ T cells were co-transfected with either GzmB-mCherry 
or GzmB-mTFP along with the v-SNAREs mVAMP2, VAMP3, VAMP4, VAMP7, and VAMP8 
constructs. Representative images from SIM are shown as indicated. Overlay of both channels 
(red and green) from all VAMPs only VAMP7 showed co-localization with GzmB. (B) Pearson’s 
and (C) Manders’ overlap coefficients for co-localization of VAMP3 (n = 16), VAMP4 (n = 14), 
VAMP7 (n = 13), VAMP8 (n = 9) and VAMP2 (n = 14) with GzmB were given in the text. (D) 
Bead-activated primary human CD8+ T cells were electroporated with EGFP-VAMP7 or 
VAMP7-pHuji and immunostained with anti-GzmB antibody conjugated with Alexa647. (E) The 
corresponding Pearson’s and (F) Manders’ overlap coefficients for co-localization of EGFP-
VAMP7 (n = 12) or VAMP7-pHuji (n = 11) with GzmB were given in the text. Data were from 
three different donors. Data indicateed were mean ± SEM. Scale bar, 5 µm. Adapted and 






3.17 VAMP7 does not colocalize with Lat-containing vesicles in 
either activated or resting CTLs 
It was shown previously in primary mouse CD4+ T cells that VAMP7 plays an 
important role in the initial phase of IS formation by regulating the recruitment and 
phosphorylation of Lat (linker for activation of T cells), a key adaptor protein 
involved in the T cell receptor signaling pathway. With confocal and TIRF 
microscopy it was shown that Lat and VAMP7 partially co-localize on vesicles close 
to the IS. (Larghi et al., 2013a). We, therefore, tested a potential co-localization of 
Lat and VAMP7 in human primary CD8+ T cells by structured-illumination 
microscopy (SIM). CTLs were electroporated with VAMP7-mCherry and after 12 h 
of transfection cells were incubated either on poly L-ornithine or CD3/CD28 coated 
coverslips and stained with anti-Lat antibody (Figure 26A). We found basically no 
co-localization either on poly-L-ornithine or CD3 coated coverslips. The Pearson’s 
coefficients of correlation of (0.03 ± 0.006 on poly L-ornithine or 0.08 ± 0.008 on 
CD3/CD28; Figure 26B) and Manders’ overlap coefficients for co-localization (0.20 
± 0.026 for VAMP7 to Lat, 0.06 ± 0.023 for Lat to VAMP7 on poly L-ornithine, 0.19 
± 0.034 for VAMP7 to Lat, 0.11 ± 0.03 for Lat to VAMP7 on CD3/CD28; Figure 
26C) rule out that VAMP7 is associated with Lat containing vesicles at resting or 
activated human primary CD8+ T cells. 
  
 
Figure 26: VAMP7 does not localize with Lat-vesicles in CD8+ T cells. 
(A) Bead-activated primary human CD8+ T cells expressed with a VAMP7-mCherry construct 
and incubated either on poly-L-ornithine or anti-CD3 coated coverslips for 15 min. Cells were 
fixed and immunostained with anti-Lat antibody. (B) The relative Pearson’s and (C) Manders’ 
overlap coefficients for co-localization of VAMP7-mCherry with Lat on Poly-L-Ornithine coated 
coverslips (n=11) or CD3-CD28 coated coverslips (n=10) were given in the text. Data indicated 






3.18 Lat-containing vesicles do not show co-localization in 
primary mouse CD4+ T cells 
Further, we also looked at the localization of VAMP7 in CD3/CD28 bead stimulated 
mouse CD4+ T cells on day 3 by transfecting with huVAMP7-mCherry. 
Subsequently cells were incubated on poly L-ornithine or CD3-CD28 coated 
coverslips for 15 min, fixed and immunostained with anti-Lat antibody (Figure 27A). 
In CD4+ T cells, we did not observe any significant co-localization of VAMP7 with 
Lat-containing vesicles with Pearson’s (0.04 ± 0.01 on poly L-ornithine and 0.02 ± 
0.006 on CD3/CD28; Figure 27B) and Manders’ co-localization coefficients (0.24 
± 0.02 on poly L-ornithine and 0.24 ± 0.01 on CD3/CD28; Figure 27C). 
   
 
Figure 27: Localization of VAMP7 with Lat-containing vesicles in mouse primary CD4+ T 
cells. 
(A) Bead-activated mouse primary CD4+ cells electroporated with VAMP7-mCherry construct 
and incubated either on poly-L-ornithine or anti-CD3 coated coverslips for 15 min, fixed and 
immunolabeled with anti-Lat antibody. (B) The corresponding Pearson’s and (C) Manders’ 
overlap coefficients for co-localization of VAMP7-mCherry with Lat on Poly-L-Ornithine coated 
coverslips (n = 12) or anti-CD3 coated coverslips (n = 11) were given in the text. Data were 
indicated as mean ± SEM. Scale bar, 5 µm. 
 
3.19 Phosphorylation of the MAP kinases Erk1 and Erk2 is 
unaltered upon VAMP7 Knockdown 
In order to confirm that VAMP7 in primary human CD8+ T cells is not involved in 
the T cell signaling pathway, we tested the phosphorylation of the kinases Erk1 
and Erk2 upon VAMP7 knockdown. In accordance with the lack of co-localization 
with Lat containing vesicles (Figure 28B & C), we also found no change in the 
phosphorylation of the microtubule-associated protein (MAP) kinases Erk1 and 
Erk2 upon VAMP7 knockdown in Western blots with a phospho-specific antibody 
used at the indicated time points compared to ns-siRNA treated cells (Figure 28A 
& C). VAMP7 protein levels were decreased >90 % upon VAMP7 siRNA1 and 2 
compared to ns siRNA treated CTLs (Figure 28B). We thus conclude that VAMP7 





Figure 28: Phosphorylation of MAP kinases Erk1 and Erk2 are unchanged upon VAMP7 
knockdown. 
(A) Lysates from Bead-activated primary human CTLs electroporated with either control or 
siRNA1 or siRNA2 against VAMP7 and activated for 0, 5 or 10 min with a monoclonal antibody 
(mAb) against CD3 and CD28 and blotted for p-MAPK (top), VAMP7 (middle) and GAPDH 
(bottom) as the loading control. (B) Densitometric quantification of VAMP7 protein levels in % 
normalized to control siRNA-treated CTLs. Data were obtained from five independent 
experiments (for siRNA1, N = 5; ***p < 0.001 and for siRNA2, N = 5; ***p < 0.001 (t-test)). (C) 
The mean intensity values for phosphorylated MAPK were calculated by western blot analysis 
which were normalized to GAPDH and displayed relative to that of unstimulated cells 
expressing control siRNA (N = 5; 0 min, p = 0.417; 5 min, p = 0.651; 10 min, p = 0.088 (One-
way ANOVA test). Bars indicated were means ± SEM. Adapted from (Chitirala et al., 2019). 
 
3.20 VAMP7 polarizes to the IS on the same granules as granzyme B and 
Perforin 
We performed our initial co-localization analysis on CD3/CD28 bead stimulated 
primary human CTLs that were not conjugated with target cells. To examine 
whether VAMP7 co-localizes with GzmB and Perforin at the time of IS formation 
when contacted with target cells, we performed on the CTLs after electroporating 
with a VAMP7-pHuji construct and observed them using SIM microscopy. After 12 
h of transfection CTLs were incubated with Raji (target cell line) cells for 5, 10 and 
15 min respectively. After fixing, the cells were stained with alexa 647-conjugated 
anti-GzmB (Figure 29A left) or anti-Perforin antibodies (Figure 29A right), 
respectively. From these experiments, we noticed that CTLs in contact with target 
cells showed a strong CG polarization towards the IS as expected. Importantly, in 
both GzmB and Perforin immunostainings we found a highly significant co-
localization of VAMP7 puncta with the GzmB or Perforin at each indicated time 
point measured, with Pearson’s coefficients of correlation of 0.58 ± 0.03 (5 min), 
0.59 ± 0.03 (10 min) and 0.60 ± 0.02 (15 min) for GzmB (Figure 29B) and 0.46 ± 
0.03 (5 min), 0.49 ± 0.03 (10 min) and 0.52 ± 0.03 (15 min) for Perforin (Figure 
29C), respectively.  
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Figure 29: VAMP7 polarizes to the IS along with CG merkers GzmB and Perforin. 
(A) Representative SIM images from staphylococcus enterotoxin-A (SEA)-pulsed human CD8+ 
T cells electroporated with VAMP7-pHuji construct (green) and conjugated with SEA pulsed 
RAJI (target) cells, fixed after indicated time points respectively. CTLs were fixed, 
permeabilized and immunostained with either Alexa647-conjugated GzmB (magenta) or 
Perforin (magenta) antibodies. (B, C) The corresponding Pearson’s overlap coefficients for co-
localization of VAMP7-pHuji with GzmB (n = 12) and VAMP7-pHuji with Perforin (n = 11) were 
given in the text. Data indicated were means ± SEM. Scale bar, 5 µm. Adapted from (Chitirala 
et al., 2019). 
3.21 VAMP2, VAMP3 and VAMP4 show no co-localization with 
GzmB and Perforin 
We tested the localization of other v-SNAREs such as VAMP2, VAMP3, and 
VAMP4 in CTLs conjugated with Raji target cells. After SEA pulsation primary 
CD8+ T cells were electroporated with either VAMP2-pHuji or EGFP-VAMP3 or 
EGFP-VAMP4 fusion constructs. After 12-16 h of transfection, CTLs were 
conjugated with SEA pulsed Raji target cells for 15 min at 37° C. After fixation, cells 
were immunostained with Alexa 647-conjugated GzmB (Figure 30A left) or Perforin 
(Figure 30A right) antibodies. We did not observe any significant co-localization of 
VAMP2, VAMP3 and VAMP4 puncta with cytotoxic granule markers at the 
indicated time point measured, with Pearson’s coefficients of correlation of 0.31 ± 
0.009 (15 min), 0.20 ± 0.012 (15 min) and 0.27 ± 0.013 (15 min) for GzmB (Figure 
30B left) and 0.24 ± 0.009 (15 min), 0.18 ± 0.014 (15 min) and 0.21 ± 0.024 (15 
min) for Perforin (Figure 30C right), respectively. In contrast to VAMP7 (see Figure 





Figure 30: VAMP2, 3 and 4 do not polarize to the IS on the same granules as GzmB and 
Perforin. 
(A) Representative SIM images of SEA-pulsed human CD8+ T cells that were electroporated 
with mVAMP2-pHuji, EGFP-VAMP3, and EGFP-VAMP4 constructs (green) respectively and 
conjugated with SEA pulsed RAJI (target) cells and fixed after 15 min. Permeabilized cells were 
further immunostained with either Alexa647-conjugated GzmB (magenta) or Perforin 
(magenta) antibodies. (B) & (C) The corresponding Pearson’s overlap coefficients for co-
localization of mVAMP2, VAMP3, and VAMP4 with GzmB (n = 15) or Perforin (n = 16) were 
given in the text. Data indicated were means ± SEM. Scale bar, 5 µm. Adapted from (Chitirala 
et al., 2019). 
 
3.22 VAMP7 fuses at the plasma membrane together with 
GzmB 
With the help of immunostainings and SIM microscopy, we demonstrated that 
VAMP7 is localized on CGs in bead activated and target cell conjugated CTLs. To 
test whether fusion of VAMP7 occurs concurrently with the release of cytotoxic 
substances (GzmB and Perforin) from CGs, we next performed TIRFM 
experiments at high temporal resolution (10 Hz). We co-transfected primary human 
CD8+ T cells with VAMP7 fused to a red fluorophore mCherry and GzmB fused to 
TFP (teal fluorescent protein) (Ai et al., 2006) constructs. After carefully adding 
CTLs on CD3-coated coverslips the IS was formed quickly (within 1-2 min) and we 
noticed a rapid arrival and accumulation of CGs, indicated by individual VAMP7-
mCherry (magenta) puncta (Figure 31A upper panel) and GzmB-TFP (green) 
puncta (Figure 31A middle panel). In conjunction with the data from (Figure 25 & 
Figure 29), the merged image showed an almost complete co-localization of 
VAMP7 with GzmB (Figure 31A lower panel). We identified individual fusion events 
which were analysed by a sudden drop in the mean fluorescence intensity of both 
VAMP7-mCherry and GzmB-TFP fluorescence simultaneously, due to the release 
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and followed by diffusion of the soluble GzmB-TFP (compare frame 3 and 4 in the 
upper panel of Figure 31A). The percentage of cells with fusion events (25.55 ± 
6.18 %; Figure 31B) and the average number of fusion events per cell (3.66 ± 0.83; 
Figure 31C) were calculated from three independent experiments. 
 
Figure 31: VAMP7 fuses at the plasma membrane together with GzmB. 
(A) Bead stimulated human CD8+ T cells were co-transfected with VAMP7-mCherry and GzmB-
TFP fusion constructs and imaged after 12 h of electroporation. Selected live-cell TIRF 
microscopy images of VAMP7-mCherry (magenta) and GzmB-TFP (green) in an electroporated 
CTL that was in contact with an anti-CD3 coated coverslip was shown. Fusion events were 
indicated with open arrowheads. (B) Mean percentage of cells with fusion events (n = 29) and 
(C) Mean average number of granules fused over time in the TIRF plane per cell (n = 29) from 
three different donors were indicated. Bars indicated were means ± SEMs. Scale bar, 5 µm. 
Adapted and modified from (Chitirala et al., 2019). 
 
3.23 VAMP7 fuses at the plasma membrane along with GzmB: 
visualization with pH-sensitive red fluorescent protein pHuji 
After demonstrating that VAMP7 ‘’fuses’’ simultaneously with the release of GzmB 
from CGs, we changed the fluorophore on VAMP7 to a pH-sensitive red fluorescent 
protein, pHuji (Shen et al., 2014) to distinguish the fusion kinetics of membrane 
protein (VAMP7) and diffusible cargo protein (GzmB). As previously, we used 
TIRFM microscopy to perform these experiments. We co-transfected human CTLs 
with VAMP7 coupled to the pH-sensitive fluorophore pHuji at C-terminus and 
GzmB coupled to mTFP. CTLs were seeded on anti-CD3 coated coverslips. The 
IS was formed quickly with a rapid accumulation of CGs that were indicated by 
individual GzmB-mTFP (green) and VAMP7-pHuji (magenta) puncta (Figure 32A 
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upper panels). In accordance with the data in (Figure 25 & Figure 29), the merged 
images showed an almost complete co-localization of vSNARE VAMP7 with the 
CG marker GzmB (white puncta in Figure 32A lower panel). We identified individual 
fusion events by a sudden drop in the mean fluorescence intensity of GzmB-mTFP 
(Figure 32B), caused by the release and subsequent diffusion of the soluble GzmB-
mTFP (compare frame 3 and 4 in the upper panel of Figure 32A). Parallel to this, 
we observed a sudden increase in fluorescence of VAMP7-pHuji that is due to the 
opening of the fusion pore and subsequent dequenching of the luminal fluorophore 
(Figure 32A; exemplary trace in Figure 32C). The magenta fluorescence remained 
after fusion as expected. These data not only showed VAMP7s’ selective 
localization on CGs before their fusion but also verifies the proteins’ integration into 
the CG membrane in the correct direction. From this data, we could distinguish the 
fusion of VAMP7 and release of GzmB simultaneously with different fusion kinetics.  
 
 
Figure 32: Visualization of VAMP7-pHuji fusion at the plasma membrane together with 
GzmB-mTFP. 
(A) Bead stimulated human CTLs were co-transfected with GzmB-mTFP and VAMP7-pHuji 
constructs and were imaged after 12 h of transfection. Selected live-cell TIRFM images of 
GzmB-mTFP and VAMP7-pHuji from an electroporated CTL which is in contact with an anti-
CD3 coated coverslip were shown (GzmB, green, upper panel; VAMP7, magenta, middle 
panel; merged, lower panel). (B & C) Graphs depicted were the mean fluorescence intensity of 
individual mTFP and pHuji vesicles over time, respectively. Experiments were performed with 





3.24 VAMP8 mediates recycling endosomal fusion whereas 
VAMP7 mediates CG fusion 
Immunoprecipitations, pulldowns and in-vitro cell fusion assays from primary 
human CD8+ T cells led to the hypothesis that VAMP8 plays an important role in 
CTL cytotoxicity by mediating multiple membrane trafficking steps during cytotoxic 
granule maturation and exocytosis (Spessott et al., 2017b). Our data (Figure 25) 
also showed an intermediate Pearson’s coefficient of correlation of VAMP8 with 
GzmB and previously, our group showed that VAMP8 is required for fusion of 
Rab11 containing recycling endosomes with the plasma membrane (the key step 
before CG exocytosis) in primary human CD8+ T cells. The t-SNARE, Syntaxin11 
was deposited at the plasma membrane by recycling endosomes to help 
assembling SNARE complexes that are required for cytotoxic granule exocytosis 
at the plasma membrane (Marshall et al., 2015). Thus, we did TIRF experiments 
after co-transfection of VAMP7-mCherry and VAMP8-mTFP constructs in human 
CD8+ T cells to verify the role of VAMP8. If VAMP8 is involved in the final fusion 
step of CGs with the plasma membrane (Dressel et al., 2010; Loo et al., 2009), we 
expect a co-localization of both VAMP isoforms at the IS. In agreement with the 
co-localization data of GzmB with different isoforms of VAMP (Figure 25A-C), in 
which VAMP7 and VAMP8 proteins were localized on different vesicles, there was 
virtually no co-localization at the IS. During IS formation, VAMP8-containing 
vesicles arrived much earlier at the IS (green puncta) (Figure 33A) and fused 
earlier with ten-fold higher frequency than VAMP7-containing vesicles (red puncta) 
(Figure 33B-D). This result confirmed our earlier findings (Marshall et al., 2015) 
and rules out a role of VAMP8 in the fusion of CGs with the plasma membrane in 






Figure 33: VAMP8 and VAMP7-containing vesicle fusion at the IS. 
(A) Bead activated human CTLs were co-transfected with VAMP7-mCherry and VAMP8-mTFP 
constructs and imaged after 12 h of transfection. Selected live-cell TIRFM images of VAMP7-
mCherry and VAMP8-mTFP from an electroporated CTL which is in contact with an anti-CD3 
coated coverslip (VAMP7, red, upper panel; VAMP8, green, middle panel; merged, lower 
panel). (B) Individual fusion events (arrows) of VAMP7- (upper panel) and VAMP8-containing 
vesicles (lower panel) at the indicated time points of recording were shown from representative 
cell. (C) Mean cumulative fusion events in the TIRF plane per cell (N = 3, n = 39, ***p < 0.001 
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(t-test)). (D) Mean average number of VAMP7- and VAMP8-containing vesicles in the TIRF 
plane per cell in the first 3.5 minutes of measurements were displayed (N = 3, n = 39, ***p < 
0.001 (Mann-Whitney U-test)). Bars indicated were means ± SEMs. Scale bar, 5 µm. Adapted 
and modified from (Chitirala et al., 2019). 
 
3.25 Knockdown of VAMP7 strongly reduces fusion of 
cytotoxic granules at the IS 
Our data demonstrate that VAMP7 co-localizes with the GzmB and Perforin until 
CGs fuse with the plasma membrane at the IS. To investigate the functional 
involvement of VAMP7 in the fusion of CGs with the plasma membrane, we carried 
out TIRFM experiments after down-regulating VAMP7 protein. We electroporated 
human CD8+ T cells with two different VAMP7 siRNAs (siRNA1 and 2) and with 
GzmB-mCherry. VAMP7 siRNA1 and 2 reduced the expression of VAMP7 to 10.5 
± 3.9% (VAMP7 siRNA1) and 8.5 ± 1.9% (VAMP7 siRNA2) of the original level, 
respectively (Figure 34A & B) in contrast to a scrambled control siRNA which had 
no effect. We observed a reduction in the number of CTLs showing CG fusion to 
less than 50% of the control after expressing VAMP7 siRNAs (from 57.8 ± 4.8% to 
22.2 ± 4.4% for VAMP7 siRNA1 and from 67.1 ± 1.8% to 14.4 ± 3.4% for VAMP7 
siRNA2, respectively; Figure 34D). Simultaneously, the average number of CG 
fusion events observed in CTLs expressing VAMP7 siRNAs was also reduced 
(from 2.8 ± 0.7 to 1.6 ± 0.4 for VAMP7 siRNA1 and from 3.2 ± 0.2 to 0.9 ± 0.4 for 
VAMP7 siRNA2, respectively; Figure 34E). As a second independent assay we 
used recently developed calcein-based killing assay to measure the CG release 
from CTLs. we used a recently developed, calcein-based killing assay (Kummerow 
et al., 2014) to measure the CG release from CTLs. For that, we used CD8+ T cells 
isolated from SEA pulsed PBMCs and SEA pulsed Raji (target) cells that were 
incubated for 4 h at 37 °C at 1 to 10 (Target to T cell ratio). Prior to the assay, 
target cells were incubated with calcein-AM dye. In agreement with our TIRF data, 
after 4 h of incubating T cells with target cells, we observed a significant reduction 
of killing of targets in CTLs electroporated with VAMP7 siRNA1 (20.7 ± 2.1 %) and 
VAMP7 siRNA2 (16.6 ± 3.0 %) compared to scrambled siRNA treated cells (52.04 





Figure 34: VAMP7 knockdown strongly decreases the cytotoxic granule fusion at the IS. 
(A) Lysates from bead stimulated human CD8+ T cells electroporated with either control or 
VAMP7 siRNA1 or 2, respectively and blotted for VAMP7 (top) and GAPDH (bottom) as the 
loading control. (B) Quantification of VAMP7 protein levels (in % normalized to control siRNA-
treated CTLs) performed by densitometry (VAMP7-siRNA1, N = 3; ***p < 0.001 and VAMP7-
siRNA2, N = 3; ***p < 0.001 (t-test)). (C) Primary human CD8+ T cells were co-transfected with 
-----Results----- 
 81 
GzmB-mCherry along with either ns-siRNA or VAMP7-siRNA1 or 2 and imaged 12 h after 
transfection. Selected live-cell TIRF microscopy images of GzmB-mCherry in an electroporated 
CTL in contact with an anti-CD3 coated coverslip were shown. Fusion events were indicated 
with open circles (three frames shown per granule fused). (D) Mean percentage of cytotoxic 
granules fused in cells electroporated with either ns-siRNAs (n=66 and n = 59, respectively) or 
VAMP7-siRNA1 (n = 91; **p < 0.01 (t-test)) or VAMP7-siRNA2 (n = 72; ***p < 0.001 (t-test)). 
(E) Mean average number of granules fused over time in the TIRF plane per cell (p = 0.206 (t-
test) for VAMP7-siRNA1 and **p < 0.01 (t-test) for VAMP7-siRNA2. (F) Calcein-based killing 
assay performed in primary CD8+ T cells electroporated with ns-siRNA, VAMP7-siRNA1 or 
VAMP7-siRNA2. Experiments were carried out in duplicates from four donors (N = 4; ***p < 
0.001 (t-test)). Bars indicated were means ± SEM. Scale bar, 5 µm. Adapted from (Chitirala et 
al., 2019). 
 
3.30 VAMP4 knockdown has no effect on fusion of cytotoxic 
granules at the IS  
In an NK cell line (YTS), it was demonstrated that VAMP4 and VAMP7 were 
associated with Perforin containing cytotoxic granules when YTS cells conjugated 
with target cells (Krzewski et al., 2011b). siRNA mediated downregulation of 
VAMP4 resulted in a significant reduction in degranulation but did not influence 
IFN-γ secretion. To test the effect of VAMP4 on CG fusion, we observed cytotoxic 
granule exocytosis. We performed TIRFM in primary human CTLs co-transfected 
with VAMP4 siRNA together with GzmB-mCherry as CG marker for visualizing 
exocytosis. Knockdown of VAMP4 was very efficient compared to ns-siRNA 
treated cells and was confirmed by semi-quantitative PCR, which showed much 
less expression of VAMP4 cDNA (11.85 ± 2.73 %) compared to ns-siRNA treated 
cells (Figure 35B). In agreement with the results from (Figure 35A-C), we did not 
observe any difference in the percentage of cells showing secretion in VAMP4 
siRNA treated cells (52.62 ± 1.35 %) in comparison to ns siRNA treated cells (52.61 
± 1.77 %) or in the average number of granules fusing per cell in VAMP4 siRNA 
treated cells (2.79 ± 0.47) in comparison to ns siRNA treated cells (3.84 ± 0.36) 
(Figure 35C & D). These results indicate that VAMP4 has no role in CG exocytosis 






                                  
Figure 35: Knockdown of VAMP4 has no effect on the fusion of cytotoxic granules at the 
IS. 
(A) Bead-activated primary human CD8+ T cells electroporated with ns-siRNA or siRNA against 
VAMP4 as indicated. The bands on agarose gel show VAMP4 cDNA levels after 12 h of 
transfection by semi-quantitative PCR. (B) VAMP4 cDNA levels quantified by densitometry 
normalized to GAPDH (N = 3, ***p < 0.001; (t-test)) from three independent experiments. (C) 
The mean percentage of cytotoxic granule fusion in cells electroporated with either ns-siRNA 
(n = 82) or VAMP4-siRNA1 (n = 53) (N = 3, p = 0.997; (t-test)) are shown. (D) Mean average 
number of granules fused over time in the TIRF plane per cell for ns-siRNA (n = 82) and 
VAMP4-siRNA1 (n = 53) (N = 3, p = 0.154; (t-test)). Bars indicate ± SEMs. Adapted from 
(Chitirala et al., 2019). 
 
3.31 VAMP7 knockdown has no effect on fusion of recycling 
endosomes  
We then tested recycling endosomes fusion (VAMP8 mediated), which usually 
occurs before CG fusion at the IS (Marshall et al., 2015) by co-transfecting human 
CD8+ T cells with siRNA against VAMP7 and Rab11a (a marker for recycling 
endosomes) fused to GFP. TIRFM analysis of these cells showed no difference in 
the percentage of CTLs with recycling endosome fusion of VAMP7 siRNA treated 
CTLs (48.6 ± 4.9 %) or ns siRNA treated CTLs (52.3 ± 3.06 %), nor was there a 
difference in the average number of recycling endosomal fusion events per cell in 
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VAMP7 siRNA treated CTLs (9.70 ± 1.88) when compared to ns siRNA (6.9 ± 0.6) 
(Figure 36A & B).  
                                    
Figure 36: Rab11a fusion at the plasma membrane is unchanged upon VAMP7 
knockdown. 
(A) Bead stimulated primary human CD8+ T cells co-transfected with mCherry-Rab11a 
construct either with ns-siRNA or VAMP7-siRNA1 and imaged after 12 h of electroporation. 
Mean percentage of cytotoxic granules fused in cells electroporated with VAMP7-mCherry for 
ns-siRNA (n = 44) and VAMP7-siRNA1 (n = 46) (N = 3, p = 0.558; (t-test)) (B) Mean average 
number of granules fused over time per cell in the TIRF plane for ns-siRNA (n = 44) and 
VAMP7-siRNA1 (n = 46) (N = 3, p = 0.107; (t-test)). Data were pooled from three different 
donors. Bars indicated were means ± SEMs. Adapted from (Chitirala et al., 2019). 
 
3.32 VAMP7 forms a SNARE complex with Syntaxin11 and 
SNAP-23 
Having identified VAMP7 as the V-SNARE in the fusion of CGs with the plasma 
membrane at the IS, we have examined which additional SNAREs are involved in 
the CG fusion event. In general, fusion processes are mediated by a SNARE 
complex consisting of a vesicular SNARE (v-SNARE) residing on the vesicular 
membrane and target SNAREs (t-SNAREs) on the target membrane ( 
Figure 37A). We attempted to identify the corresponding SNARE partners of 
VAMP7. For that purpose, we generated Twin-Strep-tag tagged fusion proteins for 
VAMP7 at the C-terminus (VAMP7-Flag-Twin-Strep-tag) and Twin-Strep-tag 
tagged Syntaxin11 at the N-terminus (Twin-Strep-tag-Syntaxin11;  
Figure 37B) attached with a flexible linker (GGSGGSGGS) and expressed these 
constructs in human CTLs. Pull-downs assays performed with human CTLs 
overexpressing tagged VAMP7-Strep-tag identified a specific band for both SNAP-
23 and Syntaxin11 proteins. This data indicates that SNAP-23 and Syntaxin11 
were the most likely t-SNARE partners for VAMP7 ( 
Figure 37C). Conversely, lysates of CTLs expressing tagged Syntaxin11 showed 
SNAP-23 and VAMP7 in pulled down assay ( 
Figure 37D). Importantly, VAMP2 was not detected in the pull-down assays, 
demonstrating the specificity of the SNARE complex we identified ( 
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Figure 37D). We also analysed the amount of SNARE proteins pulled down with 
the respective Twin-Strep-tag pulldown assays ( 
Figure 37E & F). In conclusion, these results indicate that SNAP-23 and 
Syntaxin11 are t-SNARE partners for CG fusion mediated by VAMP7 in primary 
CD8+ T cells. 
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Figure 37: VAMP7 forms a SNARE complex with SNAP-23 and Syntaxin11.  
(A) Model illustrates the SNARE complex formation between VAMP7 (v-SNARE), SNAP-23 
and Syntaxin11 (t- SNARE) during CG fusion in primary human CD8+ T cells. (B) Various Twin-
Strep-tag fusion constructs were used for pulldown assay. For VAMP7, Twin-Strep-tag was 
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fused at the C terminus and for Syntaxin11; it was fused at the N terminus with (GGSGGSGGS) 
linker in between. (C) Bead stimulated primary human CD8+ T cells were electroporated with 
VAMP7-Twin-Strep-tag construct. Cells were lysed after 12-16 h and lysates were incubated 
with Strep-Tactin sepharose beads. The precipitates were analysed with FLAG, SNAP-23, and 
Syntaxin11 antibodies respectively. (D) Bead stimulated primary human CD8+ T cells 
electroporated with Twin-Strep-tag-tagged Syntaxin11. Cells were lysed, and the lysates were 
incubated with Strep-Tactin sepharose beads. The precipitates were analysed with antibodies 
against Strep-tag, SNAP-23, VAMP7, and VAMP2. Cells were electroporated with Twin-Strep-
tag construct (as a control). 10% of the lysates were loaded as input. (Chitirala et al., 2019)(E) 
& (F) The relative amount of co-precipitated SNAREs quantified by densitometry. Bars 
indicated were means ± SEMs. Adapted from (Chitirala et al., 2019). 
 
3.33 Overexpression of VAMP7 longin domain inhibits CG 
transport to IS 
We have shown that VAMP7 silencing leads to a decrease in the percentage of 
CG fusion at the IS. VAMP7 consists of a long N-terminal domain in comparison to 
other VAMP isoforms (Figure 38A). Such longin domain overexpression inhibits 
neurite outgrowth, whereas longin domain deletion activates SNARE-complex 
assembly and stimulates the growth of neurites in staurosporine-differentiated 
PC12 cells (Martinez-Arca et al., 2000). We used TIRFM microscopy to investigate 
the proposed auto-inhibitory mechanism of the longin domain in primary human 
CD8+ T cells. For that, we generated a VAMP7 longin domain (first 1-110 aa of 
VAMP7) fusion construct with mCherry and co-transfected with CG marker GzmB-
mTFP to visualize the effect of the longin domain on granule polarization and fusion 
at the IS on CD3 coated coverslips. Interestingly, we observed significant 
differences both in the percentage of cells showed secretion in VAMP7 (longin 
domain) electroporated cells (14.07 ± 4.07 %) compared to the cells that are 
electroporated with GzmB-mTFP alone (45.37 ± 2.44 %) and in the average 
number of granules fused per cell in VAMP7 (longin domain) electroporated cells 
(0.44 ± 0.23) compared to the cells that are electroporated with GzmB-mTFP alone 
(1.69 ± 0.44) (Figure 38C & D). In addition, we also observed fewer CGs appearing 
in the TIRF field in the case of VAMP7 (longin domain) transfection (Figure 38B) 
and a three-fold higher frequency of fusion, (Figure 38E) indicating a role of the 




Figure 38: Longin domain affects CG trafficking to the plasma membrane.  
(A) A schematic showing the VAMP7 longin domain (LD)-mCherry fusion construct design. (B) 
Bead stimulated primary human CD8+ T cells electroporated with GzmB-mTFP alone or co-
transfected with VAMP7 (LD)-mCherry and GzmB-mTFP constructs and imaged after 12 h of 
transfection. Selected live-cell TIRFM images of GzmB-mTFP in a electroporated CTL in 
contact with an anti-CD3 coated coverslip (GzmB, upper panel; GzmB (co-transfected with 
VAMP7 (LD)-mCherry), middle panel; VAMP7 (LD)-mCherry and epifluorescence image, lower 
panel). (C) Mean cumulative fusion events in the TIRF plane per cell (N = 3, n = 35 and 48, ***p 
< 0.001 (t-test)). (D) Mean average number of granules fused per cell (N = 3, n = 35 and 48, 
***p < 0.001 (t-test)). (E) Mean average number of GzmB-containing vesicles in the TIRF plane 
per cell in the first 5 minutes of measurements (N = 3, n = 10 and 13, ***p < 0.001 (Mann-





3.34 VAMP7 longin domain does not alter recycling endosomal 
transport to the IS 
We then examined the effect of VAMP7 longin domain overexpression on recycling 
endosomal transport to the IS. Since we showed (Figure 33) that the recycling 
endosomal fusion to the plasma membrane is mediated by VAMP8, we expected 
no difference in the transport of Rab11a containing vesicles to the plasma 
membrane upon VAMP7 longin domain overexpression. The VAMP7 longin 
domain fusion construct with mCherry was co-transfected with the recycling 
endosomal marker EGFP-Rab11a construct to visualize granule polarization and 
fusion at the IS on CD3 coated coverslips. As expected, we did not observe any 
significant difference in either the percentage of cells with secretion in VAMP7 
(longin domain) electroporated cells (42.22 ± 2.22 %) compared to the cells that 
are electroporated with EGFP-Rab11a alone (44.85 ± 1.1 %) or in the average 
number of granules fused per cell in VAMP7 (longin domain) electroporated cells 
(27.55 ± 2.23) in comparison to EGFP-Rab11a alone (31.37 ± 0.77) (Figure 39B & 
C). We also observed no difference between the average numbers of granules 
approaching the TIRF plane in EGFP-Rab11a electroporated cells as compared to 
VAMP7 longin domain electroporated cells (Figure 39D).  
This data confirms our previous and current findings, which strongly indicate that 
VAMP7 longin domain plays an important role in the function of primary human 
CD8+ T cells by regulating the transport of CGs and inhibits fusion at the plasma 




   
Figure 39: Longin domain has no effect on the recycling endosomal trafficking to the 
plasma membrane.  
(A) Bead activated primary human CD8+ T cells electroporated with EGFP-Rab11a construct 
alone or co-transfected with VAMP7 (LD)-mCherry construct and imaged after 12 h of 
transfection. Selected live-cell TIRFM images of EGFP-Rab11a from an electroporated CTL 
which is in contact with an anti-CD3 coated coverslip (Rab11a, upper panel; Rab11a (co-
transfected with VAMP7 (LD)-mCherry), middle panel; VAMP7 (LD)-mCherry and epi 
fluorescence image, lower panel). (C) Mean cumulative fusion events in the TIRF plane per cell 
(N = 3, n = 49 and 45, p = 0.349 (t-test)). (D) Mean average number of granules that were fused 
per cell (N = 3, n = 49 and 45, p = 0.182 (t-test)). (E) Mean average number of Rab11a-
containing vesicles that appeared in the TIRF plane per cell in the first 5 minutes of 
measurements (N = 3, n = 10 and 11, *p < 0.035 (Mann-whitney Rank Sum Test)). Data 
indicated were means ± SEM. Scale bar, 5 µm. 
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Further, we aim to visualize the fusion of CGs in live mouse using two-photon 
microscopy. For that purpose, we designed a strategy to replace the monomeric 
red fluorescent protein mRFP from Syb2-mRFP mice with pH-sensitive, ratiometric 
fluorophore with high brightness. 
  
Generation of Synaptobrevin2 knock-in mice 
3.35 Amplification of mTFP, TagRFP-T and pHluorin2 
In parallel to the before described functional projects on isolated CTLs from human 
and mouse, we also generated several Knock-in mouse lines where 
Synaptobrevin2 was fused to different fluorescent markers. For that, we selected 
mTFP (photostable fluorophore), TagRFP-T (10x more photostable than TagRFP) 
and pHluorin2 (ratiometric pH-sensitive fluorophore). NPY-mTFP plasmid was 
used as a template for amplifying mTFP. TagRFP-T was amplified from pCR259-
TagRFP-T construct (gift from Dr. Peter Lipp, Uniklinik, Homburg). pHluorin2 was 
synthesized from IDT (IDT custom gene synthesis program). The amino acid 
sequence from pHluorin2 was codon optimised for Mus musculus. 
























     
Figure 40: Amplification strategy for mTFP, TagRFP-T and pHluorin2.   
(A) Schematic representation of the amplification strategy for mTFP, (B) TagRFP-T and (C) 
pHluorin2 with forward primer (with kpn1) and reverse primer (with Not1 and HindIII). 
 
3.36 Cloning of targeting vectors 
For the generation of Synaptobrevin2-Knock-in mouse, Synaptobrevin-2-mRFP 
targeting vector (Matti et al., 2013) was used. In the targeting vector, the stop 
codon in the last coding exon (Exon 5) of the Synaptobrevin2 gene was replaced 
in-frame by the coding region for mTFP or TagRFP-T or pHluorin2. Targeting 
vector has a cassette containing the neomycin resistance gene under the control 
of the CMV promoter and the Cre-recombinase gene under the control of a testis-
specific promoter flanked by two loxP sites from plasmid pACN (kindly provided by 
M. Capecchi) downstream of the mTFP or TagRFP-T or pHluorin2 STOP codon. 
One copy of the HSV (herpes simplex virus) thymidine kinase gene was present at 
the 3’ end of the targeting vector. Targeting vector was digested with Not1 
restriction site to remove the Synaptobrevin2-mRFP and replace with 
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Synaptobrevin2-mTFP from pCDNA3.1(-) (used as a shuttle vector to clone 
Synaptobrevin2-mTFP, Synaptobrevin2-TagRFP-T and Synaptobrevin2-
pHluorin2 with 5’-Not1 and 3’-Not1 & HindIII restriction sites). Both targeting vector 
and inserts were ligated and screened for clones with inserts in correct orientation 






Figure 41: Cloning strategy of Synaptobrevin2 targeting vectors.   
(A) Schematic representation of the targeting vector digestion (B) Cloning of Synaptobrevin2-
mTFP (C) Synaptobrevin2-TagRFP-T and (D) Synaptobrevin2-pHluorin2 targeting vectors from 
pCDNA3.1 (-) shuttle vector. 
 
3.37 Electroporation of Embryonic Stem (ES) cells and 
generation of Synaptobrevin2 knock-in offspring 
Successful homologous recombination results in the insertion of this construct into 
the endogenous Synaptobrevin2 locus on chromosome 11. The construct was 
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linearized using the Swa1 restriction enzyme and then the purified linearized 
construct was sent to Dr. Ectors at the GIGA institute at the University of Liège, for 
electroporation into R1 embryonic stem (ES) cells. Following targeting, one 96 well 
plate containing individual ES cell clones were sent to us for analysis. We 
performed Southern blot analysis using the enzyme Kpn1 and a 32P-labelled 900 
bp probe, which anneals 5’ to the 5’-most extreme of the targeting construct. This 
allows us to distinguish between the wild type allele, producing a 17.4 Kb band and 
the correctly targeted Synaptobrevin2-mTFP or TagRFP-T or pHluorin2-Cre-
containing knock-in allele which gives an 11.3 Kb band (Figure 42D).  
Following Southern analysis, DNA from 96 clones (from Synaptobrevin2-TFP) 
could be visualized upon the membrane of which 55 were positive, giving a 
targeting frequency of 57.29 %. Clone B06 was injected and chimeras were 
obtained. After reaching adulthood, 3 males with 100 % chimerism were crossed 
with C57BL/6 females and the resulting offspring were genotyped by PCR for the 
presence of the Synaptobrevin2-TFP allele. These heterozygous mice were then 
imported into the animal facility in Homburg where they are now maintained as a 
heterozygous line and being backcrossed to with C57BL/6N mouse strain.  
DNA from 96 clones (from Synaptobrevin2-TagRFP-T) could be visualized upon 
the membrane of which 36 were positive, giving a targeting frequency of 37.5 %. 
Clone D01 was injected and chimeras were obtained. After reaching adulthood, 3 
males with 100 % chimerism were crossed with C57BL/6 females and the resulting 
offspring were genotyped by PCR for the presence of the Synaptobrevin2-
TagRFP-T allele. These heterozygous mice were then imported into the animal 
facility in Homburg where they are now maintained as a heterozygous line and 
being backcrossed to with C57BL/6N mouse strain. 
DNA from 86 clones (from Synaptobrevin2-pHluorin2) could be visualized upon the 
membrane of which 13 were positive, giving a targeting frequency of 13.54 %. 
Clone C06 was injected and chimeras were obtained. After reaching adulthood, 3 
males with 100 % chimerism were crossed with C57BL/6 females and the resulting 
offspring were genotyped by PCR for the presence of the Synaptobrevin2-
pHluorin2 allele. These heterozygous mice were then imported into the animal 
facility in Homburg where they are now maintained as a heterozygous line and 
being backcrossed to with C57BL/6N mouse strain. 
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Figure 42: Generation of Syb2 knock-in mouse. 
(A) Targeting strategy of Synaptobrevin2-mTFP (B) Synaptobrevin2-TagRFP-T & (C) 
Synaptobrevin2-pHluorin2 knock-in mouse leaving the synaptobrevin2 gene locus intact except 
for the addition of the coding sequence for GGSGGSGGT linker and TFP. (D) Southern blot 
analysis for ES cell targeting. Both 17.4kb and 11.3kb bands confirm Knock-in. 
 
3.37 Expression and Fusion of CGs from Synaptobrevin2-
mTFP (+/-) knock-in  
Unfortunately, we could not get any homozygous animals from all three knock-in 
mice even after backcrossing the mice with C57BL/6N mice strain for 10 
generations. Among all the three mouse lines, only Syb2-mTFP (+/-) knock-in 
mouse showed expression in primary CD8+ T cells. SIM images showed relatively 
bright puncta (Figure 43A) and we were able to visualize the fusion of CGs in the 
TIRF plane on an anti-CD3 coated coverslip with the addition of 10 mM calcium-
containing extracellular solution (Figure 43B). 
 
Figure 43: Visualization of CG fusion from Syb2-mTFP (+/-) CTLs. 
(A) Representative SIM images from day 5 Syb2-mTFP heterozygous mouse CD8+ T cell. (B) 
TIRF images shows the individual fusion events (granule 1; upper panel and granule 2; lower 
panel). Individual fusion events were depicted with open arrows. (C) Graphs depicted were the 
mean fluorescence intensity of individual mTFP vesicles over time, respectively. Experiments 





Our findings define a major role of the a3-subunit in mouse primary CD8+ T cells. 
a3-subunit downregulation inhibits the acidification of CGs thus, affecting the 
morphology of CGs. This leads to a defect in trafficking of cytotoxic granules toward 
the IS affecting the main function of CTLs. We showed that among four ‘a’ subunit 
isoforms, three were expressed in CTLs. We demonstrated that downregulation of 
the a3 isoform resulted in a reduced number of CGs approaching the TIRF plane 
followed by a strong reduction in CG secretion compared to control cells. The 
knockdown of a1 and a2 subunits did not alter the pH of CGs.   
We also showed that the a3 subunit is co-localized with the CG marker GzmB using 
a polyclonal antibody against a3. We could not detect any interaction of ‘c’ or ‘a’ 
subunits with synaptobrevin2 indicating that in mouse primary CTLs a3 is not 
involved in the fusion mechanism of CGs. 
Finally, by using electron microscopy we demonstrated that a3 knockdown 
changes the morphology of CGs thus affecting the transport and fusion of CGs at 
the IS. We also observed that upon a3 down-regulation the dense core of the CGs 
less matrix than those of control cells. This presumably resulted in the inactivation 
of GzmB inside CGs and degradation of Perforin which are crucial for CTL function. 
 
4.1 Expression of the a3 isoform 
In mice, Northern blot analysis of the a3-subunit isoform shows its ubiquitous 
expression in all tissues such as heart, brain, spleen, lung and kidney but majorly 
in the liver (Toyomura et al., 2000). TCIRC7, an alternative splice variant lacking 
first 217 aa in the hydrophobic region of a3 was shown to have a major role in T 
cell activation in vitro and in vivo (Susani et al., 2004) (Heinemann et al., 1999). In 
mouse endocrine cells (pancreatic β-cells), the a3 subunit localizes on insulin-
containing secretory granules and regulates insulin secretion. Though mutant mice 
with defective V-ATPase subunits produced insulin in mature form, they were less 
competent for hormone secretion. Thus, indicating a specific role of a3 in 
membrane fusion (Sun-Wada et al., 2006).  
The a3-isoform is also highly expressed in adrenal, parathyroid, pituitary and 
thyroid glands indicating its functional relevance in various exo- and endocytic 
pathways and mammalian hormone secretion (Sun-Wada et al., 2007). 
We could demonstrate that immunostaining of a3 subunit with a polyclonal 
antibody showed punctate staining in mouse CTLs that co-localized significantly 
with CGs with Pearson’s colocalization coefficients above 0.5 with endogenous 
synaptobrevin2 (Figure 14). Many puncta did not colocalize with CGs that might be 
due to a3 localized on lysosomes (Toyomura et al., 2003). We also checked the 
expression of ‘a’ subunit isoforms in CD3/CD28 bead stimulated CTLs that showed 
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expression of a1, a2 and a3 (highly expressed compared to other isoforms) but not 
a4 (Figure 13A). 
 
4.2 Functional diversity of a3-subunit 
The V-ATPase is essential for vesicular trafficking during the early stages of 
development. From yeast to mammals lack of V-ATPase subunits lead to lethal 
developmental abnormalities. In Caenorhabditis elegans silencing three of four a- 
subunit isoforms leads to death during early developmental stages (Oka et al., 
2001). The a3 isoform is also involved in bone homeostasis by providing an acidic 
environment in lacuna (compartment formed between the plasma membrane and 
bone surface) for bone matrix degradation. Similarly, in humans, mutations in a3 
isoform (Tcirg1) results in lethal autosomal recessive osteopetrosis (Frattini et al., 
2000) (Kornak et al., 2000) and is also co-localized with d2 subunit in human 
osteoclasts. Whereas, knockout of d2-subunit in mice leads to defective osteoclast 
function resulting in increased bone mass (Lee et al., 2006).  
In a macrophage cell line (RAW264.7), a3 is localized on lysosomes and found 
along with other lysosomal enzymes on the plasma membrane upon stimulation. 
This confirms its targeting from lysosomes to the plasma membrane suggesting its 
role in lysosomal exocytosis. Similarly, lysosomal exocytosis from phagocytes, 
neutrophils and monocyte-derived cells including osteoclasts and macrophages 
requires the V-ATPase subunit indicating its important role in fusogenic activity in 
general. However, the role of other V-ATPase subunits in vesicular trafficking 
cannot be ignored. 
Since the a3 knockout mice die within four weeks due to severe osteopetrosis, we 
used specific siRNAs against the a3 protein in our studies. After 12 h of 
transfection, we observed an efficient decrease in a3 protein levels verified by 
western blot analysis (Figure 14D). The pH measurements conducted with a pH- 
sensor inside the CGs revealed that upon a3 knockdown alone the pH inside CGs 
was altered (raised from pH 6.1 to pH 7) (Figure 14E). We also showed by electron 
microscopy that a3 knockdown CTLs displayed changes in the morphology of CGs 
compared to control cells (Figure 22). This is on par with observations from 
(Kataoka et al., 1994) demonstrating the effect of concanamycin-A (CMA: V-
ATPase inhibitor) on OE4 cells (special CD8+ clone). CMA treated OE4 cells 
showed CGs with irregular shapes, empty, swollen, fused and divided granules 
devoid of small vesicles with impaired killing efficiency when conjugated with 
(p815) target cells. However, CMA treatment did not alter the surface expression 
of TCR, CD3, CD8 and CD11a. 
We took the advantage of GzmB-mTFP knockin mice, which express a GzmB-
mTFP fusion protein endogenously (see Figure 16A-D). Even though mTFP is 
cleaved off inside the CGs with an unknown mechanism (verified by western blot), 
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we checked the activity of the remaining GzmB. By using Casper3-GR reverse fret 
construct with DEVD (target cleavage site for active GzmB), we proved that the 
GzmB inside CGs was active (Figure 16F) and also showed that it is released upon 
stimulus on anti-CD3 coated coverslips performed with TIRFM (Figure 16E). siRNA 
mediated downregulation of a3 combined with TIRFM studies in primary CTLs 
revealed that cells devoid of a3 show reduction in the average percentage of CTLs 
with secretion (Figure 17A-C ) and importantly, the average number of CGs 
appearing in the TIRF plane were drastically reduced (Figure 17D). These results 
led us to investigate the role of a3 in the transport of CGs along the microtubules 
(a prerequisite for granule polarization).  
 
4.3 V-ATPase interaction with small GTPases: Functional 
significance 
Acidic pH is crucial for vesicular trafficking in all cell types. The tightly regulated 
processes such as multi-vesicular body (MVBs) or endosomal carrier vesicles 
(ECVs) and exosome formation and secretion is dependent upon acidification in 
early endosomes in BHK cells (Clague et al., 1994). It has been shown in the 
recruitment of coatomer proteins and Arf1 (small GTPase) onto early endosomes 
in an acidification-dependent manner (Aniento et al., 1996). In kidney epithelial 
cells, intra endosomal acidic pH drives the recruitment of ARNO (ADP-ribosylation 
factor nucleotide site opener)/Arf6 and their interaction with V-ATPase c-subunit is 
important for protein trafficking between early and late endosomes during protein 
degradation pathway (Hurtado-Lorenzo et al., 2006). Recently, using a3-KO mice, 
it was shown that V-ATPase a3-subunit has a dual function in acidifying lacunae 
and secretory lysosome trafficking via Rab7 recruitment (Matsumoto et al., 2018). 
These biochemical interaction assays were performed in HEK293T cells and we 
have carried out similar experiments in primary activated CTLs. Other reports 
showed that V-ATPase can directly interact with the actin-microfilament 
cytoskeleton and that it requires an intact microtubular network to detach between 
V0V1 domains (Forgac, 2007a). These molecular interactions between V-ATPase 
and small GTPases indicate that GTPases might function as on/off switches for 
the V-ATPase function. 
These studies encouraged us to examine the role of the a3-subunit in mouse CD8+ 
T cells. We show that a3 knockdown by gene silencing using siRNAs leads to a 
strong reduction in the average number of CGs appearing in the TIRF plane (see 
Figure 17D) a similar phenotype to the reported defective secretory lysosomal 
trafficking in osteoclasts. We also performed Twin-Strep-tag pulldown assays with 
Rab7a and Rab27a (both dominant negative and dominant active forms) fusion 
constructs expressed in primary mouse CTLs. We did not detect any interaction of 
GTPase with a3-subunit (Figure 19& Figure 20). This indicates that there might be 
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other Rabs interacting with a3 in mouse CTLs or that the interaction might be 
transient and not detected with our pulldown assay. 
Taken together, in agreement with the above-described findings and based on our 
results, it is evident that a3 plays a major role in mediating CG fusion in primary, 
mouse CTLs. siRNA mediated knockdown in CTLs isolated from GzmB-mTFP 
knockin mice endogenously expressing fluorescent CG marker GzmB, allowed us 
to detect defective CG transport and fusion. With the help of electron microscopic 
observation on CTLs in which a3 was knocked down, we could study the 
morphology of CGs. We were unable to discover the molecular mechanism behind 
the reduced granule polarization towards the IS. Interestingly, using super-
resolution STED microscopy we could demonstrate that defective polarization of 
CGs might be due to lack of interaction between a3 on the CGs with other Rab 
proteins, which in turn interacts with kinesins for the transport of vesicles along with 
the microtubule network (Figure 21). Since the human isoform of the a3-subunit 
leads to 50% of osteopetrosis cases, a3 might serve as a major target for the 
development of innovative drugs for improving the life span in the affected 
population. 
 
vSNARE of human CTLs 
In this study, we also have examined the role of VAMP7 in CTL function. In primary 
CD8+ T lymphocytes, our findings identified VAMP7 as the vSNARE required for 
fusion of CGs with the plasma membrane at the IS. We showed that the 
downregulation of VAMP7 expression by siRNA led to a significant reduction in CG 
fusion at the IS followed by a reduction in target cell killing in vivo. We also showed 
that VAMP7 interacts with the SNARE proteins Syntaxin11 and SNAP-23 in an in 
vitro binding assay showing its possible involvement in the human disease Familial 
Haemophagocytic Lymphohistiocytosis (FHL). 
We finally showed that VAMP7 longin domain plays an important role in the 
trafficking and fusion of CGs at the IS. Whereas, recycling endosomal transport or 
fusion at the IS prior to CG fusion was unaltered. 
 
4.4 Differences in the vSNAREs mediating CG fusion in human 
and mouse cells 
SNAREs are the central components of membrane fusion. With the help of 
synaptobrevin2 knock-in mice and by using correlative light-electron microscopy 
(CLEM) it was previously reported that in primary mouse CD8+ T cells cytotoxic 
granule fusion is mediated by VAMP2 in mice (Matti et al., 2013b). In that report, it 
was also shown that syb2 co-localized with the CG marker GzmB. By using 
immunoelectron microscopy and coimmunoprecipitation studies (Mollinedo et al., 
2003) showed that VAMP2 also plays a role in the exocytosis of specific and 
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tertiary granules in human neutrophils. The Q-SNARE/R-SNARE complexes 
containing VAMP2 and syntaxin-4 were involved in the exocytosis of neutrophil 
granules. Our findings uncover an important difference in the mechanism of 
cytotoxic substances released between humans and mice. Even after tetanus toxin 
treatment, CG fusion was normal in human CTLs (Figure 23D). From this data, we 
could rule out an involvement of VAMP2 in CG fusion from human CD8+ T cells. 
This conclusion is further supported by our data that showed a lack of co-
localization of the CG marker GzmB or Perforin with VAMP2 in activated CTLs 
conjugated with target cells (Figure 25). We also found a decrease in VAMP2 
protein levels upon T cell activation in contrast to VAMP7 levels, which were 
upregulated (Figure 24). 
 
4.5 Expression of VAMP7 
Previous results indicate that in mice, the VAMP7 shows a ubiquitous expression 
and localizes to various intracellular organelles, most predominantly to late 
endosomes and lysosomes. VAMP7 localization on late endosomes is mediated 
by its longin domain interaction with the delta subunit of the adaptor protein AP-3 
(Kent et al., 2012). VAMP7 also forms a SNARE complex with SNAP-23 and 
Syntaxin4 as shown with an in vitro interaction assays in HeLa cells (Martinez-Arca 
et al., 2003). Similarly, it was demonstrated that VAMP7 is localized on late 
endosomal compartments and that it is required for heterotypic fusion of late 
endosomes with lysosomes in rat liver cell-free systems (Pryor et al., 2004b). In 
macrophages, VAMP7 mediates the fusion of late endocytic vesicles that results 
in early blockade of pseudopod extension (Braun et al., 2004a). These reports 
showed diverse roles of VAMP7 in various fusion processes and its ability to 
interact with various SNARE partners including Syntaxin1, Syntaxin3, Syntaxin4, 
Syntaxin7, Syntaxin8, SNAP-23 and SNAP-25.  
Our findings with the help of super-resolution microscopy and overexpression of 
VAMP7 fusion constructs (either N or C terminus) demonstrate that VAMP7 is co-
localized to a higher degree with GzmB and Perforin proteins on CGs from human 
CTLs as compared to other VAMPs (VAMP2, VAMP3, VAMP4 and VAMP8) 
(Figure 25A). This might be because CGs are lysosome-related organelles and 
VAMP7 also in other systems shows affinity to lysosomes. Similarly, in cultured 
primary astrocytes, VAMP7 is localized to lysosomes and acts as a vSNARE 
mediating secretory lysosome exocytosis, leading to release of ATP and cathepsin 
B from glial cells (Verderio et al., 2012). This suggests a potential role of VAMP7 
in exocytosis of CGs in CTLs too.  
In contrast to the “brevin” family of VAMPs like synaptobrevin 1 or 2, VAMP7 has 
an additional N-terminal domain called longin domain (first 6-110 aa of VAMP7), 
which is involved in controlling the SNARE complex assembly through interaction 
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with coiled-coil domains of several proteins (Martinez-Arca et al., 2003; Vivona et 
al., 2010). For example VAMP7, through its longin domain interaction with AP-3 
(clathrin adaptor), Varp (guanine exchange factor) and Hrb (endocytic protein) 
determines its subcellular localization in various cell types (Burgo et al., 2009; 
Chaineau et al., 2008; Martinez-Arca et al., 2003; Pryor et al., 2008). Because of 
its diverse subcellular localization, VAMP7 has been associated with several 
membrane trafficking steps that include fusion of late endosomes to lysosomes, 
Golgi apparatus to plasma membrane exocytosis, and autophagosomal and 
lysosomal exocytosis (Advani et al., 1999; Braun et al., 2004b; Fader et al., 2012; 
Oishi et al., 2006; Pocard et al., 2007; Pryor et al., 2004a).  
By using siRNA mediated knockdown of VAMP7 or VAMP7 KO mice it was shown 
(Larghi et al., 2013b) that VAMP7 is involved in the recruitment of vesicular Lat to 
the TCR-activation sites that is required for the Lat phosphorylation and T cell 
activation in primary CD4+ T cells. They also showed that VAMP7 knockdown 
resulted in a decrease in phosphorylation signaling molecules (PLC-γ1, SLP-76 
and MAP kinases Erk1 and Erk2 along) indicating a defective signalosome 
formation during T cell activation if VAMP7 is missed. In contrast, using SIM we 
found no co-localization with Lat containing vesicles either in resting or activated 
human CD8 and mouse CD4 positive CTLs (Figure 26 & Figure 27) excluding its 
role in T cell signaling pathway in primary human CD8+ T cells. 
 
4.6 Functional diversity of VAMP7 
VAMP7 is involved in various cellular processes including cell polarization through 
apical transport (in epithelial cells), neuronal outgrowth (in PC12 cells and cultured 
neurons), synaptic transmission, lysosomal secretion (fibroblasts), membrane 
repair, cell migration, mitosis, and phagocytosis (formation of plasma membrane 
extensions at the sites of phagocytosis) (Chaineau et al., 2009; Daste et al., 
2015a). In dendritic cells, VAMP7 regulates the secretion of IL-12, induced by 
contact with a cognate antigen-specific CTL (Chiaruttini et al., 2016). In rat 
enterocytes, VAMP7 is expressed in the endoplasmic reticulum (ER) but it is not 
present in the ER of kidney or liver. It plays an important role in the transport of 
triacylglycerol from ER to cis Golgi in the form of pre-chylomicron transport vesicles 
(PCTVs) (Siddiqi et al., 2006).  
From all reported studies, it appears that VAMP7 localizes mainly in Golgi and late 
endosomes/lysosomes in most cell types. VAMP7 may have a role in anterograde 
and retrograde trafficking from Golgi and endocytosis as well. The mammalian 
post-Golgi network involves the v-SNAREs VAMP2 and VAMP3 (localize to early 
and recycling endosomes, respectively) (Das et al., 2004), VAMP4 (localizes to 
TGN) (Mallard et al., 2002), and VAMP7 and VAMP8 (involved in trafficking of 
recycling endosomes) that play a role in many intracellular trafficking steps from 
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various specialized cells (Lippert et al., 2007). Moreover, VAMP7 regulates the 
fusion of lysosome-associated membrane protein carriers that are derived from the 
trans-Golgi network with late endosomes (Pols et al., 2013). In addition it was 
suggested from in vitro studies that VAMP7 mediates heterotypic fusion between 
endosomes and lysosomes, whereas VAMP8 mediates homotypic fusion (Pryor et 
al., 2004a).  
In polarized Caco-2 (heterogeneous human epithelial colorectal adenocarcinoma) 
and MDCK (Madin-Darby Canine Kidney) epithelial cells VAMP7 forms a SNARE 
complex with Syntaxin3 and SNAP-23 (tSNARE partners) that helps in TeNT 
resistant apical exocytosis (Galli et al., 1998). 
 
4.7 Role of VAMP7 in immune cells 
Multiple roles of VAMP7 in different cell types have been demonstrated by using 
siRNA mediated gene silencing or by overexpressing its longin domain to induce 
a dominant negative effect.  
In human immune cells, both VAMP isoforms (VAMP7 and VAMP8) have been 
shown to translocate to the plasma membrane, forming a SNARE complex with 
Syntaxin4 and SNAP-23 which mediates activation-induced mast cell 
degranulation (Liu et al., 2018; Sander et al., 2008). From subcellular fractionation, 
flow cytometry and antibody inhibition studies in human eosinophils and 
neutrophils, VAMP7 also interacts with the tSNAREs Syntaxin4 and SNAP-23, 
enabling the release of eosinophil peroxidase and eosinophil-derived neurotoxin, 
myeloperoxidase, lactoferrin and matrix metalloprotease-9 (mediators) in a dose-
dependent manner (Logan et al., 2006; Mollinedo et al., 2006). In B-cells, VAMP7 
mediates the fusion of lysosomes at the IS. Thus, VAMP7 plays a critical role in 
antigen extraction and presentation (Obino et al., 2017). Finally, in both human 
primary NK cells and in NK-like cell lines (YTS cells) VAMP7 was shown to be 
involved in CG fusion (Krzewski et al., 2011a; Marcet-Palacios et al., 2008). 
VAMP7 and VAMP4 co-localized with Perforin in the CGs, and their siRNA 
mediated knockdown led to a strong reduction in degranulation activity. VAMP7 
was also shown to be involved in interferon-gamma (IFN-γ) (cytokine) release, 
indicating an indirect effect on CG fusion (Krzewski et al., 2011a). Since these 
studies did not use techniques allowing observation of CG fusion in real-time, these 
VAMP isoforms may play a role in CG maturation, which resulted in the observed 
phenotype. 
With the help of pH sensitive (pHuji) and insensitive (mTFP, mCherry) fluorophores 
combined with TIRFM studies, we found that VAMP7 fuses at the IS along with 
GzmB containing CGs on anti-CD3 coated coverslips when secretion is stimulated 
with 10 mM extracellular Ca2+ containing solution. Further, VAMP7 down-regulation 
by siRNA led to a strong reduction in the percentage of cells with CG fusion and 
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the average number of granules fused per cell (Figure 34D & E). This indicates two 
possible roles of VAMP7 in reduced CG fusion. First, due to defective transport of 
CGs toward the IS by its longin domain interactome and second, due to direct 
involvement in the formation of SNARE complex or a defect in both functions.  
Thus, our main findings from primary human CD8+ T cells showed here broaden 
the available data on human immune cells and identify the vSNARE that mediates 
CG fusion at the IS. We found a very significant co-localization of VAMP7 with 
GzmB and Perforin (CG markers), and also demonstrated the simultaneous loss 
of VAMP7 and release of GzmB at the IS. At the same time, the potential role of 
VAMP4 in the release of CG could be ruled out by both co-location studies with an 
EGFP-VAMP4 fusion construct co-transfected with GzmB-mCherry and CG fusion 
analysis by TIRFM after siRNA mediated VAMP4 knockdown (Figure 35). 
It has also been shown that in vitro VAMP7 and SNAP-23 form a SNARE complex 
with Syntaxin11, and not Syntaxin4, which mediates CG fusion in primary human 
CTLs (Figure 24). Syntaxin4 appears to be involved in the early stages of IS 
formation of CTLs by regulating, in conjunction with VAMP8, the fusion of recycling 
endosomes with the plasma membrane (Marshall et al., 2015; Spessott et al., 
2017a). In our study, we showed that CGs (containing VAMP7) arrive much later 
than recycling endosomes (containing VAMP8) and also fused with lower 
frequency thanVAMP8 vesicles (Figure 33). These data indicate that VAMP7 and 
VAMP8 play different roles in CTL function.   
 
4.8 Function of longin domain 
VAMP7 is composed of longin, SNARE and tail-anchor transmembrane domain. In 
addition to its regulatory function, the longin domain of VAMP7 plays an important 
role in the localization of the protein. It has been shown that the longin domain 
interacts with AP-3 delta subunit for its late endosomal localization in non-neuronal 
cells (Martinez-Arca et al., 2000). Consistent with the above findings, 
overexpression of only longin domain resulted in a strong reduction in the number 
of CGs appearing in the TIRF plane followed by a significant reduction in CG fusion 
(Figure 38). Whereas, Rab11 containing vesicle polarization and fusion at the IS 
was unchanged (Figure 39) in primary human CTLs. There was a slight reduction 
in the number of Rab11 containing vesicles fusing at the later time points. This 
might be due to fewer CG fusion at the plasma membrane which indirectly affects 
the requirement of recycling endosomal fusion. 
Taken together, the longin domain of VAMP7 might prove helpful in fighting lethal 
diseases in humans like FHL and allow modification of the efficiency of CTL 
cytotoxicity. In the FHL4 (Syntaxin 11 deficiency) condition, the formation of the 
SNARE complex for CG fusion involving VAMP7, SNAP-23 and Syntaxin11, is an 
all-or-none reaction. In contrast, the regulatory longin domain in VAMP7 allows for 
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a subtle interference of subcellular localization and endocytic efficiency. These 
manipulations would then allow us gradually altering the cytotoxicity of human 
CTLs in a very subtle way and at least theoretically, enable novel strategies for 
immunotherapy in pathophysiological conditions. 
In agreement with the findings described above and based on our results, it is clear 
that VAMP7 functions as the major vSNARE for the fusion of CGs in primary, 
human CTLs. Expression of fusion constructs of VAMP7 along with CG markers, 
visualization of CG fusion with TIRFM, knockdown of VAMP7 followed by killing 
assays, pulldowns with Twin-Strep-tag fusion proteins and overexpression of 
longin domain constructs allowed us to determine the molecular machinery 
involved in CG fusion. Since this process is of utmost importance to protect our 
body against infections and tumors, VAMP7 might serve as a major target for the 





In addition to the already described genetic disease mechanisms associated with 
mutations in a3 gene, identification of a functional role in CG fusion further 
enhances our understanding of the overall osteopetrosis disease. Despite having 
some unanswered questions about the exact molecular machinery involved in the 
trafficking of CGs, this study using electron microscopy and high-resolution STED 
microscopy, combined with other high-resolution microscopic techniques such as 
TIRFM (with 100 nm Z resolution) allowed us to study the role of a3 in primary 
mouse CTLs.  
Since 50 % of human osteopetrosis cases are due to mutations in Tcirg1 gene and 
lack of redundancy the a3 subunit with other V-ATPase isoforms, which could 
compensate for a3 function, this subunit could be an important therapeutic target, 
leading to alternative treatments to bone marrow transplantation.  
Based on our results from EM, a3 subunit knockdown in CTLs showed striking 
morphological defects in CGs affecting a major function of CTLs. This might be the 
reason behind the increased occurrence of incidence of infections in diseased 
individuals. Based on our current findings, we postulate that the a3 subunit might 
play a crucial role in CTL function. 
 
Identification of a vSNARE in CG fusion further enhances our understanding of 
CTL function. Despite having some unanswered questions about the exact 
molecular machinery involved in the trafficking of CGs, this study, using high-
resolution microscopy and molecular biology techniques, allowed us to study the 
role of VAMP7 in primary human CTLs. Thus, as an important protein in CG fusion, 
VAMP7 is a potential target for modulating CTL function.  
Lack of human mutations in VAMP7 or FHL phenotype might be due to redundancy 
of other VAMP isoforms that compensate for VAMP7 function. This is in line with 
our findings from VAMP7 knockdown combined with TIRFM or target cell killing 
assay that showed only 50 % reduction in CG fusion compared to control. This 
result must be verified. 
The most important function of CTLs is to release the cytotoxic substances and kill 
the target cells. Based on our current findings, we postulate that VAMP7 might play 
a dual role in the transport and fusion of CGs. Targeting the longin domain region 
specifically in CTLs and modulating it could potentially lead to treatment of 





In this study, we identified the a3 subunit of the V-ATPase as a key player mediating 
the fusion of cytotoxic granules at the immune synapse of primary mouse CD8+ T 
cells. Knockdown of this subunit seriously affects the integrity of CGs. This is due 
to the neutralization or lack of proton pumping activity of a3-subunit when its 
expression is downregulated. The life-threatening autosomal recessive infantile 
malignant osteopetrosis has led to the identification of Tcirg1 as a major cause of 
the disease. But the function of a3 isoform in CTLs is unknown.  
We measured pH in vivo by various pH sensors in CGs from primary mouse CD8+ 
T lymphocytes. In this study, we generated a GzmB-mTFP knockin mouse as a tool 
for studying CG fusion in vivo. To investigate which ‘a’ subunit isoform is involved 
in pH regulation in CGs, we used siRNA mediated knockdown approach coupled 
with high-resolution, real-time TIRF microscopy we showed that granule fusion in 
mouse CTLs is severely affected by a3 knockdown. By using quantitative PCR and 
SIM microscopy techniques, from the four ‘a’ isoforms, we showed that a1, a2 and 
a3 isoforms are expressed in mouse CTLs but only the a3 isoform is localized to 
CGs and regulates pH homeostasis in CGs. Using a calcein-AM killing assay 
combined with knockdown we demonstrated that lack of a3 dramatically reduces 
granule trafficking and fusion at the IS. We also showed with Twin-Strep-tag 
pulldown assays that a3 did not interact with either syb2 or Rab GTPases, indicating 
that other Rab proteins may be involved in the movement of CGs or that these 
interactions might be transient and cannot be detected in our experimental 
conditions. Finally, we showed by electron microscopy that a3 knockdown in CTLs 
changes the morphology of CGs dramatically. This confirms a specific role of a3 in 
CTL function. With super resolution STED microscopy we quantitatively showed 
that CGs in a3 knockdown CTLs showed greater distances from microtubules 
labelled with siR-tubulin compared to control in vivo. 
Overall, our work establishes that a3 is a crucial player in CG biogenesis by keeping 
the GzmB in active form and protecting Perforin from the degradation due to neutral 
pH. Thus, the a3 subunit helps in sustained CTL killing function. 
 
In this study, we also identified VAMP7 as the vSNARE that mediates, in 
conjunction with Syntaxin11 and SNAP-23, the fusion of cytotoxic granules at the 
immune synapse of primary human T cells. The life-threatening immune disease 
familial hemophagocytic lymphohistiocytosis type 4 (HLH4) has led to the 
identification of Syntaxin11 (tSNARE) as an essential component of the SNARE 
complex mediating cytotoxic granule fusion in human immune cells. But the 
vSNARE partner on the granule membrane was unknown.  
We used primary human CD8+ T lymphocytes to investigate which of the vSNAREs 
is involved in this process. By using high-resolution, real-time TIRF microscopy we 
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showed that granule fusion in human CTLs is not sensitive to tetanus toxin and 
excluded tetanus-sensitive VAMPs as candidates for vSNARE. Of the remaining 
tetanus-insensitive VAMPs, we demonstrated not only that VAMP7 shows a high 
degree of co-localization with the cytotoxic granule markers Perforin and GzmB, 
but that it’s knock-down also dramatically reduces granule fusion at the IS. Finally, 
we showed by Twin-Strep-tag pulldown assay that VAMP7 forms a complex with 
SNAP-23 and Syntaxin11, thus identifying the members of the SNARE complex 
that drives fusion. We also showed that overexpression of VAMP7 (longing domain) 
in CTLs not only inhibited granule polarization in cells coated with anti-CD3 antibody 
but also reduced the average percentage of cells showing CG fusion without 
affecting the endosomal exocytosis. This confirms a specific role of VAMP7 longin 
domain in CG fusion.  
Overall, our work establishes that VAMP7 is a central member of the fusion 
machinery for cytotoxic granules in human T lymphocytes. Because of the unique 
features of the N-terminus of VAMP7, the longin domain, VAMP7 might actually 
become a preferential target for drug development in immunotherapy of HLH and 
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